Query gi|254780493|ref|YP_003064906.1| phosphoribosylaminoimidazole-succinocarboxamide synthase [Candidatus Liberibacter asiaticus str. psy62]
Match_columns 323
No_of_seqs 170 out of 1571
Neff 6.2
Searched_HMMs 39220
Date Mon May 30 01:30:27 2011
Command /home/congqian_1/programs/hhpred/hhsearch -i 254780493.hhm -d /home/congqian_1/database/cdd/Cdd.hhm
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 PRK12607 phosphoribosylaminoim 100.0 0 0 750.7 26.5 295 1-297 1-295 (295)
2 PRK13961 phosphoribosylaminoim 100.0 0 0 709.0 25.5 282 1-295 2-297 (297)
3 cd01414 SAICAR_synt_Sc non-met 100.0 0 0 665.4 25.6 264 14-291 1-279 (279)
4 PRK13959 phosphoribosylaminoim 100.0 0 0 625.7 25.6 273 17-308 1-335 (335)
5 PRK13960 phosphoribosylaminoim 100.0 0 0 605.8 24.1 294 8-313 13-361 (367)
6 TIGR00081 purC phosphoribosyla 100.0 0 0 544.9 18.8 275 8-296 22-371 (374)
7 cd01415 SAICAR_synt_PurC bacte 100.0 0 0 529.2 22.0 226 14-290 1-229 (230)
8 PRK09362 phosphoribosylaminoim 100.0 0 0 526.5 23.2 232 10-292 2-236 (238)
9 pfam01259 SAICAR_synt SAICAR s 100.0 0 0 526.3 18.7 240 11-274 1-243 (243)
10 cd01416 SAICAR_synt_Ade5 Ade5_ 100.0 0 0 513.3 22.9 237 11-289 3-250 (252)
11 COG0152 PurC Phosphoribosylami 100.0 0 0 512.6 20.6 242 11-291 3-247 (247)
12 cd00476 SAICAR_synt 5-aminoimi 100.0 0 0 498.0 21.0 228 14-290 1-230 (230)
13 TIGR02735 purC_vibrio phosphor 100.0 0 0 459.2 19.1 294 8-313 14-360 (365)
14 KOG2835 consensus 100.0 8.7E-40 2.2E-44 273.5 9.0 306 4-318 3-370 (373)
15 KOG2835 consensus 99.0 6.4E-11 1.6E-15 89.5 -0.6 142 84-255 88-233 (373)
16 TIGR01648 hnRNP-R-Q hnRNP-R, Q 98.2 1.3E-08 3.4E-13 74.7 -6.2 142 177-323 139-285 (611)
17 KOG0117 consensus 94.2 0.00022 5.6E-09 47.9 -8.8 106 213-323 194-304 (506)
18 pfam01259 SAICAR_synt SAICAR s 89.1 0.79 2E-05 25.2 4.6 102 128-257 104-209 (243)
19 COG3473 Maleate cis-trans isom 58.0 3.1 7.8E-05 21.4 0.2 88 90-204 64-151 (238)
20 TIGR01828 pyru_phos_dikin pyru 52.7 17 0.00044 16.6 6.9 144 169-322 63-225 (920)
21 KOG0667 consensus 51.4 18 0.00045 16.6 3.2 112 176-312 290-405 (586)
22 TIGR00513 accA acetyl-CoA carb 50.3 11 0.00029 17.8 2.1 52 84-144 108-166 (329)
23 cd05594 STKc_PKB_alpha STKc_PK 49.6 19 0.00049 16.3 7.0 38 181-218 101-139 (324)
24 cd05625 STKc_LATS1 STKc_LATS1: 49.4 20 0.0005 16.3 6.5 33 188-221 113-146 (382)
25 KOG1228 consensus 48.9 20 0.00051 16.3 5.1 67 36-107 55-134 (256)
26 TIGR01825 gly_Cac_T_rel pyrido 44.6 23 0.00059 15.8 3.4 199 17-258 139-368 (392)
27 pfam07347 CI-B14_5a NADH:ubiqu 40.9 7.1 0.00018 19.1 -0.2 19 264-282 30-48 (97)
28 TIGR00706 SppA_dom signal pept 38.8 28 0.00072 15.3 3.0 151 71-231 44-220 (224)
29 cd05595 STKc_PKB_beta STKc_PKB 38.6 29 0.00073 15.3 7.5 31 188-218 107-138 (323)
30 PTZ00284 protein kinase; Provi 37.0 30 0.00077 15.1 5.6 36 277-312 327-362 (467)
31 cd05570 STKc_PKC STKc_PKC: Ser 34.1 34 0.00086 14.8 5.1 60 188-254 108-170 (318)
32 KOG1407 consensus 32.9 15 0.00038 17.0 0.5 108 27-147 117-241 (313)
33 cd06658 STKc_PAK5 Serine/threo 32.2 36 0.00092 14.6 6.3 88 188-295 130-218 (292)
34 cd05615 STKc_cPKC_alpha STKc_c 31.7 37 0.00094 14.6 8.6 33 188-221 113-146 (323)
35 cd07832 STKc_CCRK The catalyti 31.1 38 0.00096 14.5 8.2 114 177-309 101-215 (286)
36 pfam08491 SE Squalene epoxidas 30.6 38 0.00098 14.4 3.6 10 311-320 215-224 (276)
37 TIGR00389 glyS_dimeric glycyl- 29.4 29 0.00073 15.2 1.4 18 51-68 292-309 (606)
38 pfam05712 MRG MRG. This family 28.7 41 0.0011 14.2 3.9 17 304-320 90-106 (190)
39 PRK04028 glutamyl-tRNA(Gln) am 28.6 42 0.0011 14.2 3.3 34 241-282 435-468 (631)
40 pfam05121 GvpK Gas vesicle pro 28.4 42 0.0011 14.2 3.2 44 165-208 39-82 (89)
41 cd07847 STKc_CDKL1_4 The catal 27.4 44 0.0011 14.1 8.1 103 190-311 114-217 (286)
42 TIGR01811 sdhA_Bsu succinate d 27.3 42 0.0011 14.2 2.0 97 168-266 195-303 (620)
43 TIGR03643 conserved hypothetic 27.2 3 7.7E-05 21.5 -3.9 43 190-232 7-49 (72)
44 KOG1000 consensus 26.1 17 0.00045 16.6 -0.2 18 204-221 207-224 (689)
45 TIGR00601 rad23 UV excision re 24.4 26 0.00067 15.5 0.5 26 268-293 323-348 (453)
46 PRK09279 pyruvate phosphate di 23.8 51 0.0013 13.7 7.6 27 169-198 710-736 (875)
47 pfam04947 Pox_VLTF3 Poxvirus L 23.7 51 0.0013 13.7 5.5 14 247-260 54-67 (171)
48 cd05613 STKc_MSK1_N STKc_MSK1_ 23.7 51 0.0013 13.7 10.8 108 167-295 100-208 (290)
49 cd07850 STKc_JNK The catalytic 23.4 52 0.0013 13.6 7.8 106 182-309 125-231 (353)
50 pfam10985 DUF2805 Protein of u 22.5 3.9 1E-04 20.8 -4.1 42 191-232 7-48 (73)
51 cd05601 STKc_CRIK STKc_CRIK: S 22.5 54 0.0014 13.5 6.7 61 189-254 115-177 (330)
52 PTZ00034 40S ribosomal protein 22.5 36 0.00091 14.7 0.8 22 249-282 84-105 (137)
53 cd07864 STKc_CDK12 The catalyt 22.2 55 0.0014 13.5 6.9 100 181-299 122-222 (302)
54 PHA02130 hypothetical protein 21.8 55 0.0014 13.4 1.7 28 240-267 7-34 (81)
55 TIGR02800 propeller_TolB Tol-P 21.7 45 0.0011 14.0 1.2 24 173-196 139-163 (439)
56 cd07836 STKc_Pho85 The catalyt 21.3 57 0.0015 13.4 8.1 43 177-221 102-145 (284)
No 1
>PRK12607 phosphoribosylaminoimidazole-succinocarboxamide synthase; Provisional
Probab=100.00 E-value=0 Score=750.67 Aligned_cols=295 Identities=57% Similarity=1.030 Sum_probs=290.2
Q ss_pred CCCCCCCCCCCCCEEEECCEEEEEECCCCCEEEEEECCEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCEECCCC
Q ss_conf 95300054889960230440265875999489998188125557657778788999999999999854102331213577
Q gi|254780493|r 1 MRILSKAYIPELPNYYSGKVRENYFLSDGTRITIATDRLSAFDQNIACIPYKGEVLNQITQYWFHHTSDICSNHTLDYPD 80 (323)
Q Consensus 1 m~~l~~~~~~~l~liy~GKvk~vY~~~d~~ll~v~tDriSAfD~~~~~Ip~KG~~l~~iS~~~F~~l~~~i~tH~i~~~~ 80 (323)
|++|++|+||+|+++|+||||+||+++|+++|||+||||||||+++++|||||++||+||+|||++|+++|+||+++.++
T Consensus 1 m~~l~~t~~~~l~~iy~GKvrdvY~~~d~~ll~v~tDriSAFD~v~~~IpgKG~vl~~iS~~wF~~l~~~i~nH~i~~~~ 80 (295)
T PRK12607 1 MTTLLEADLPELPNYYRGKVRDNYDLPDGRRILITTDRISAFDVVLATIPFKGQVLTQTARYWFEATKDICPNHVISYPD 80 (295)
T ss_pred CCCHHHCCCCCCCCCCCCCCCEEEECCCCEEEEEEECCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCC
T ss_conf 96522247999850026668357874999399999588546542268999767999999999999720748704751577
Q ss_pred CCCCEEEECCCCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCH
Q ss_conf 63000000254650578852122443220012210247651344663212223568874022321033334577755554
Q gi|254780493|r 81 PNVLVGQQLQMFPIELIVRGYLAGNTKTSLLTFYKNGKRKIYEYLLPDNMSDNQKLPYPVITPTTKSSESASGCDQPISP 160 (323)
Q Consensus 81 ~~~~~v~k~~~iPiE~VvR~y~~GS~~~~~~~~~k~~~~~~~g~~lp~gl~~~~~l~~Pi~tpstK~~~~~~~~D~~i~~ 160 (323)
++.|+||||+|||||||||||+|||+|++|+++|+.|.+++||+++|+|+.++++||+||||||||++++ +||++|++
T Consensus 81 ~~~~lvkk~~~iPiE~VvRgy~aGS~~k~y~~~y~~g~~~~~g~~lp~gl~~~~~Lp~PiftpstK~d~~--~hD~~Is~ 158 (295)
T PRK12607 81 PNVVLGRRLTVLPVECVVRGYLAGSTWTSILTLYKAGERTMYGERLPDGLRENQKLPPPIFTPTTKAFEG--GHDEPLTI 158 (295)
T ss_pred CHHHEEEECEEEEEEEEECCCEECHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEECCCCC--CCCCCCCH
T ss_conf 3122010021664577752710021168888775047753126556654446766888745566303334--78877777
Q ss_pred HHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEEEEECCCCCEEEECCCCCCCCCHHHCCCHHHHHHHC
Q ss_conf 56665304998999899999999999999998867978874232445508862576200048100000000000123312
Q gi|254780493|r 161 NEIIHRGILTRNQWETISSYALSLFERGCKLALENGLILVDSKYEFGIDKKQNIILADEIHTPDSSRYWEVETYEKSFRE 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~i~~~sl~i~~~~~~~~~~~GliLvD~K~EFG~~~~g~iiL~DEv~TPDssR~W~~~~ye~~~~~ 240 (323)
+++++.++++++++++|++.|+++|+.++++++++||+|||||||||++.+|+|+|+|||+||||||||++++|++++..
T Consensus 159 ~~i~~~~l~~~e~~~~i~~~sl~i~~~~~~~~~~~GiiLvDtK~EFG~d~~G~iiL~DEi~TPDSsR~W~~~~Y~~~~~~ 238 (295)
T PRK12607 159 AEIVARGLLTDEQWYTLESMALALFTRGEEIAAEQGLILADTKYEFGRDADGRIILADEIHTPDSSRYWAADSYPARFAP 238 (295)
T ss_pred HHHHHHCCCCHHHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEECCCCCCCCEEEEEECCCCCCCCCCCHHHHHHHHCC
T ss_conf 89998658988999999999999999999999978978998523312669998899764048850124424343454316
Q ss_pred CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 544443237888765531122367999998989999999999999998608866478
Q gi|254780493|r 241 GITPIGLDKDFIRNWILTRCNPYRDNIPDIPENIILRTSQTYIAAYEKITGLKFIAD 297 (323)
Q Consensus 241 g~~~~s~DKq~~R~wl~~~~~~~~~~~P~LP~~vv~~~~~~Y~~~~e~lTG~~f~~~ 297 (323)
|.+|+||||||+||||.+++|++.+++|+||++|++.|++||+++||||||++|+++
T Consensus 239 g~~~~s~dKq~vR~~l~~~~~~~~~~~P~lp~~iv~~t~~rY~~~ye~lTG~~fv~~ 295 (295)
T PRK12607 239 GRRPPSFDKDFLRDWVDARCDPYNDEIPEIPAEVVEATSARYIDAYERITGQRFVPD 295 (295)
T ss_pred CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf 999765278999999984467778989989999999999999999999868786899
No 2
>PRK13961 phosphoribosylaminoimidazole-succinocarboxamide synthase; Provisional
Probab=100.00 E-value=0 Score=709.02 Aligned_cols=282 Identities=38% Similarity=0.700 Sum_probs=269.1
Q ss_pred CCCCCCCCCCCCCEEEECCEEEEEECCCCCEEEEEECCEEEECCCCC-CCCCHHHHHHHHHHHHHHHHHHHCCCCEECCC
Q ss_conf 95300054889960230440265875999489998188125557657-77878899999999999985410233121357
Q gi|254780493|r 1 MRILSKAYIPELPNYYSGKVRENYFLSDGTRITIATDRLSAFDQNIA-CIPYKGEVLNQITQYWFHHTSDICSNHTLDYP 79 (323)
Q Consensus 1 m~~l~~~~~~~l~liy~GKvk~vY~~~d~~ll~v~tDriSAfD~~~~-~Ip~KG~~l~~iS~~~F~~l~~~i~tH~i~~~ 79 (323)
|++|++++||+|+++|+|||||||+++|+++|||+||||||||++++ +|||||++||+||+|||++|+++||||+|+.+
T Consensus 2 ~~~~~~~~l~~l~l~~~GKVRdvY~~~d~~ll~v~tDRiSAFD~v~~~~IP~KG~vL~~iS~fwF~~l~~~ipnH~i~~~ 81 (297)
T PRK13961 2 MSTLTESDLPSLPLLYRGKVRDIYDIGDDRLLMVATDRISAFDVVLPEPIPDKGRVLTQISNFWFDKLADIVPNHLTGTP 81 (297)
T ss_pred CCHHHHCCCCCCCCCCCCCCCEEEECCCCEEEEEEECCCCEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 41353168999851036567237864999799999588620143368899967899999999999998605777422588
Q ss_pred CC-------------CCCEEEECCCCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEE
Q ss_conf 76-------------30000002546505788521224432200122102476513446632122235688740223210
Q gi|254780493|r 80 DP-------------NVLVGQQLQMFPIELIVRGYLAGNTKTSLLTFYKNGKRKIYEYLLPDNMSDNQKLPYPVITPTTK 146 (323)
Q Consensus 80 ~~-------------~~~~v~k~~~iPiE~VvR~y~~GS~~~~~~~~~k~~~~~~~g~~lp~gl~~~~~l~~Pi~tpstK 146 (323)
.+ ++|+|+||+|||||||||||+|||+|++| + ..+++||+++|+|+.++++||+||||||||
T Consensus 82 ~~~~~~~~~~~~~~~R~mlvkk~~~iPiE~VvR~y~aGS~~~~Y----~-~~g~~~G~~lp~gl~e~~~L~~Pi~tpstK 156 (297)
T PRK13961 82 DPSVVPADEAEQVLGRAVVVKKLKPLPVECVVRGYLTGSGWKDY----Q-ATGTVCGIKLPEGLREAQKLPEPIFTPATK 156 (297)
T ss_pred CCCCCHHHHHHHHCCCCEEEEECCCCCEEEEEECCCCCHHHHHH----H-HCCCCCCCCCCCCCCCCCCCCCCCCCHHHH
T ss_conf 61133045555414753046532536668998554043247777----5-338554775883311146689853264455
Q ss_pred CCCCCCCCCCCCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEEEEECCCCCEEEECCCCCCCCC
Q ss_conf 33334577755554566653049989998999999999999999988679788742324455088625762000481000
Q gi|254780493|r 147 SSESASGCDQPISPNEIIHRGILTRNQWETISSYALSLFERGCKLALENGLILVDSKYEFGIDKKQNIILADEIHTPDSS 226 (323)
Q Consensus 147 ~~~~~~~~D~~i~~~~~~~~~~~~~~~~~~i~~~sl~i~~~~~~~~~~~GliLvD~K~EFG~~~~g~iiL~DEv~TPDss 226 (323)
++.| .||++|+++++++ ++|++++++++++++++|+.++++|+++||+|||||||||++.+|+|+|+|||+|||||
T Consensus 157 a~~g--~hD~~is~~~~~~--~~g~e~~~~i~~~sl~i~~~~~~~a~~~GiiLvDtK~EFG~d~~g~iiL~DEi~TPDSs 232 (297)
T PRK13961 157 AELG--EHDENISFEEVVE--RVGAELAAQLRDVTLALYKRAAEYAAERGIIIADTKFEFGLDEDGTLVLIDEVLTPDSS 232 (297)
T ss_pred HHHC--CCCCCCCHHHHHH--HCCHHHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEEEEECCCCCEEEEEECCCCCCC
T ss_conf 3323--7765579999998--71999999999999999999999999889679720123224699988997503688522
Q ss_pred HHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCC
Q ss_conf 000000001233125444432378887655311223679999989899999999999999986088664
Q gi|254780493|r 227 RYWEVETYEKSFREGITPIGLDKDFIRNWILTRCNPYRDNIPDIPENIILRTSQTYIAAYEKITGLKFI 295 (323)
Q Consensus 227 R~W~~~~ye~~~~~g~~~~s~DKq~~R~wl~~~~~~~~~~~P~LP~~vv~~~~~~Y~~~~e~lTG~~f~ 295 (323)
|||++++|++ |..|+||||||+||||.+++|++.+++|+||++|+.+|++||+++||+|||++|.
T Consensus 233 RfW~~~~y~~----G~~~~s~DKq~vRdwl~~~~~~~~~~~P~lP~~iv~~t~~~Y~~~ye~iTG~~fe 297 (297)
T PRK13961 233 RYWPADGYQV----GTNPPSFDKQFVRDWLETSGWDKTPPAPPLPAEVIEKTAEKYIEALERLTGESFD 297 (297)
T ss_pred CCCCHHHHCC----CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCC
T ss_conf 3453443027----9986544779999999965999999999999999999999999999998688789
No 3
>cd01414 SAICAR_synt_Sc non-metazoan 5-aminoimidazole-4-(N-succinylcarboxamide) ribonucleotide (SAICAR) synthase. Eukaryotic, bacterial, and archaeal group of SAICAR synthetases represented by the Saccharomyces cerevisiae (Sc) enzyme, mostly absent in metazoans. SAICAR synthetase catalyzes the seventh step of the de novo biosynthesis of purine nucleotides (also reported as eighth step). It converts 5-aminoimidazole-4-carboxyribonucleotide (CAIR), ATP, and L-aspartate into 5-aminoimidazole-4-(N-succinylcarboxamide) ribonucleotide (SAICAR), ADP, and phosphate.
Probab=100.00 E-value=0 Score=665.43 Aligned_cols=264 Identities=44% Similarity=0.749 Sum_probs=250.4
Q ss_pred EEEECCEEEEEECCCCCEEEEEECCEEEECCCCC-CCCCHHHHHHHHHHHHHHHHHHHCCCCEECC-------------C
Q ss_conf 0230440265875999489998188125557657-7787889999999999998541023312135-------------7
Q gi|254780493|r 14 NYYSGKVRENYFLSDGTRITIATDRLSAFDQNIA-CIPYKGEVLNQITQYWFHHTSDICSNHTLDY-------------P 79 (323)
Q Consensus 14 liy~GKvk~vY~~~d~~ll~v~tDriSAfD~~~~-~Ip~KG~~l~~iS~~~F~~l~~~i~tH~i~~-------------~ 79 (323)
++|+||||+||+++|+++||||||||||||++++ .|||||++||+||+|||++|+++||||||+. +
T Consensus 1 l~~~GKvrdvY~~~d~~ll~v~tDriSAFD~v~~~~Ip~KG~vl~~iS~~wF~~l~~~i~nH~i~~~~~~~~~~~~~~~~ 80 (279)
T cd01414 1 LIYSGKVRDVYDLGDGRLLFVATDRISAFDVILPPDIPGKGEVLTQISAFWFELTEDIIPNHLISTDVEDLPEIKEPEDP 80 (279)
T ss_pred CCCCCCCCEEEECCCCEEEEEEECCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCCCCCCCCC
T ss_conf 97565564468759984999995886235633678999648999999999999985548863743666322332211357
Q ss_pred CCCCCEEEECCCCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCC
Q ss_conf 76300000025465057885212244322001221024765134466321222356887402232103333457775555
Q gi|254780493|r 80 DPNVLVGQQLQMFPIELIVRGYLAGNTKTSLLTFYKNGKRKIYEYLLPDNMSDNQKLPYPVITPTTKSSESASGCDQPIS 159 (323)
Q Consensus 80 ~~~~~~v~k~~~iPiE~VvR~y~~GS~~~~~~~~~k~~~~~~~g~~lp~gl~~~~~l~~Pi~tpstK~~~~~~~~D~~i~ 159 (323)
++++|+|+||+|||||||||||+|||+|++| +++ +++||+.||+||+++++||+||||||||+++ +||++||
T Consensus 81 ~~r~m~vkk~~~iPiE~IvRgyl~GS~~~~Y----~~~-~~~~g~~lp~Gl~e~~kL~~Pi~tpstK~~~---~hD~~is 152 (279)
T cd01414 81 DGRSMVVKKAKPIPIECIVRGYLTGSGWKEY----QKG-GTVCGIKLPEGLREAQKLPEPIFTPSTKAEE---GHDENIS 152 (279)
T ss_pred CCCEEEEEEEEEEEEEEEEECCCCCHHHHHH----CCC-CCCCCCCCCCCCCCCCCCCCCEEEEEECCCC---CCCCCCC
T ss_conf 9864798740463179999554054324220----367-7114863787654566689853566523566---8998779
Q ss_pred HHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEEEEECCCCCEEEECCCCCCCCCHHHCCCHHHHHHH
Q ss_conf 45666530499899989999999999999999886797887423244550886257620004810000000000012331
Q gi|254780493|r 160 PNEIIHRGILTRNQWETISSYALSLFERGCKLALENGLILVDSKYEFGIDKKQNIILADEIHTPDSSRYWEVETYEKSFR 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~i~~~sl~i~~~~~~~~~~~GliLvD~K~EFG~~~~g~iiL~DEv~TPDssR~W~~~~ye~~~~ 239 (323)
++++++ +++++++++++++|+++|+.++++|+++||+|||||||||++.+|+|+|+|||+||||||||++++|++
T Consensus 153 ~~~~~~--~~~~~~~~~i~~~sl~i~~~~~~~~~~~GiiLvDtK~EFG~~~~g~iiL~DEi~TPDssR~W~~~~y~~--- 227 (279)
T cd01414 153 FEEAVE--IIGAELADELRELALALYERAAEYAAKRGLILADTKFEFGLDENGEIILIDEVLTPDSSRFWPADSYEP--- 227 (279)
T ss_pred HHHHHH--HCCHHHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEEEEECCCCCEEEEEECCCCCCCCCCCHHHCCC---
T ss_conf 999998--669999999999999999999999998898899302452065899889985137985202332110036---
Q ss_pred CCCCCCCCCHHHHHHHHHHCCCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHC
Q ss_conf 2544443237888765531122367-999998989999999999999998608
Q gi|254780493|r 240 EGITPIGLDKDFIRNWILTRCNPYR-DNIPDIPENIILRTSQTYIAAYEKITG 291 (323)
Q Consensus 240 ~g~~~~s~DKq~~R~wl~~~~~~~~-~~~P~LP~~vv~~~~~~Y~~~~e~lTG 291 (323)
|..|.||||||+||||..++|+++ +++|+||++|++.|+++|+++||+|||
T Consensus 228 -g~~~~s~DKq~vRd~l~~~~~~~~~~~~p~lP~evi~~~~~~Y~~~ye~ltg 279 (279)
T cd01414 228 -GKEQPSFDKQFVRDWLEASGWDKQDPPPPPLPAEVIEKTSARYIEAYERITG 279 (279)
T ss_pred -CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHCC
T ss_conf -9995433679999999964998678999999999999999999999997209
No 4
>PRK13959 phosphoribosylaminoimidazole-succinocarboxamide synthase; Provisional
Probab=100.00 E-value=0 Score=625.67 Aligned_cols=273 Identities=28% Similarity=0.418 Sum_probs=249.4
Q ss_pred ECCEEEEEECCC------CCEEEEEECCEEEECC-CCC-CCCCHHHHHHHHHHHHHHHHHHH-CCCCEECCC--------
Q ss_conf 044026587599------9489998188125557-657-77878899999999999985410-233121357--------
Q gi|254780493|r 17 SGKVRENYFLSD------GTRITIATDRLSAFDQ-NIA-CIPYKGEVLNQITQYWFHHTSDI-CSNHTLDYP-------- 79 (323)
Q Consensus 17 ~GKvk~vY~~~d------~~ll~v~tDriSAfD~-~~~-~Ip~KG~~l~~iS~~~F~~l~~~-i~tH~i~~~-------- 79 (323)
.|||||+|.+++ +++||||||||||||+ +|+ +||+||++||+||+|||++|+++ ||||+++.+
T Consensus 1 ~GKVRDiY~~~~~~~~~~~~ll~V~TDRiSAFD~~vlp~~IP~KG~vL~~iS~fWF~~l~~~gIpnH~i~~~~~~~~~~~ 80 (335)
T PRK13959 1 MGSVKDLYVDEPPTETDLGRGVFVFSDRYSVFDWGIMPDEIPDKGESLCRMGAYWFELLEELGIKTHYIGLVEGDKVRLD 80 (335)
T ss_pred CCCCCEEEECCCCCCCCCCEEEEEEECCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCCCH
T ss_conf 99744442258654567874899980886534525146999973299999999999977646988603135675432200
Q ss_pred ----CCCCCEEEECC-----------------------CCCCEEEEECCC-CCCCCCCHHHHHHCCCCCCCCCCCCCCCC
Q ss_conf ----76300000025-----------------------465057885212-24432200122102476513446632122
Q gi|254780493|r 80 ----DPNVLVGQQLQ-----------------------MFPIELIVRGYL-AGNTKTSLLTFYKNGKRKIYEYLLPDNMS 131 (323)
Q Consensus 80 ----~~~~~~v~k~~-----------------------~iPiE~VvR~y~-~GS~~~~~~~~~k~~~~~~~g~~lp~gl~ 131 (323)
.++.|+|++++ |||||||||||+ +|| ++++|+++|...+||+.+|+||+
T Consensus 81 ~~~~~~~~m~v~~~~v~~~~~~~~~~~~~~~~~~~~~~miPiE~IvRgYl~~gs---s~~~~~~~g~v~~~gi~lp~gl~ 157 (335)
T PRK13959 81 EAKSAPNEMVVKLTQVPKLPFEDGSYDYSIFHAAGGNYLIPLEFIFRNYVPVGS---SLRDRIKPGEVKPEDIGLDEWPE 157 (335)
T ss_pred HCCCCCCEEEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEECCCCCCH---HHHHHHHCCCCCCCCCCCCCCCC
T ss_conf 025887536888731145433443211110001243565577999942305732---79998864871204777886543
Q ss_pred CCCCCCCCCEEEEEECCCCCCCCCCCCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEEEEECCC
Q ss_conf 23568874022321033334577755554566653049989998999999999999999988679788742324455088
Q gi|254780493|r 132 DNQKLPYPVITPTTKSSESASGCDQPISPNEIIHRGILTRNQWETISSYALSLFERGCKLALENGLILVDSKYEFGIDKK 211 (323)
Q Consensus 132 ~~~~l~~Pi~tpstK~~~~~~~~D~~i~~~~~~~~~~~~~~~~~~i~~~sl~i~~~~~~~~~~~GliLvD~K~EFG~~~~ 211 (323)
++++||+||||||||+++ ||++||++++.+++.++.+++++|+++|+++|+.++++|+++||||||||||||++.+
T Consensus 158 ~~~kLp~PifTPsTKae~----hD~~is~~e~~~~~g~~~a~~~~l~~~sl~ly~~~~~~a~~~GiILaDTKfEFG~d~d 233 (335)
T PRK13959 158 YGEKLPEPIVEFSTKLEE----TDRYLSRSEALEIAGLSDAEIEELEELARKIDEIITEEVEKRGLIHEDGKKEFALDLE 233 (335)
T ss_pred CCCCCCCCEEECCCCCCC----CCCCCCHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEEEEECCC
T ss_conf 457488763303456645----8988899999987599999999999999999999999999789868864056017799
Q ss_pred CCEEEECCCCCCCCCHHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC-----------------CCCCCCCCHHH
Q ss_conf 6257620004810000000000012331254444323788876553112236-----------------79999989899
Q gi|254780493|r 212 QNIILADEIHTPDSSRYWEVETYEKSFREGITPIGLDKDFIRNWILTRCNPY-----------------RDNIPDIPENI 274 (323)
Q Consensus 212 g~iiL~DEv~TPDssR~W~~~~ye~~~~~g~~~~s~DKq~~R~wl~~~~~~~-----------------~~~~P~LP~~v 274 (323)
|+|+|+|||+||||||||.. +.++||||+|+|+...+|.. .+++|+||++|
T Consensus 234 g~lvLiDEvlTPDSSRf~~~------------~~~~~Kq~~r~~~~~~~w~~~~~~~~~~~~~~w~~~~~~~pP~LP~ev 301 (335)
T PRK13959 234 REIMVVDVVGTFDEDRFSFE------------GVEVSKEMVRQYYRRTEWVDAVYEAKEEDVADWKGLCEPSPPPLPDEI 301 (335)
T ss_pred CCEEEEEECCCCCCCCCCCC------------CCCCCHHHHHHHHHHCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHH
T ss_conf 97899986689862346888------------877686888889872454455555201443233234689999999999
Q ss_pred HHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHH
Q ss_conf 9999999999999860886647886789999999
Q gi|254780493|r 275 ILRTSQTYIAAYEKITGLKFIADNSELPPLERIR 308 (323)
Q Consensus 275 v~~~~~~Y~~~~e~lTG~~f~~~~~~~~~~erI~ 308 (323)
|++|++||+++||+|||++|++.++..++++||+
T Consensus 302 v~~t~~rY~eayerlTG~~f~~~~~~~~~~~~~~ 335 (335)
T PRK13959 302 IQAVSDLYKAGYNRITGRKWFDAPPLKDALDALK 335 (335)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHCC
T ss_conf 9999999999999986885668997220576509
No 5
>PRK13960 phosphoribosylaminoimidazole-succinocarboxamide synthase; Provisional
Probab=100.00 E-value=0 Score=605.81 Aligned_cols=294 Identities=32% Similarity=0.475 Sum_probs=251.5
Q ss_pred CCC--CCCEEEECCEEEEEECC------------------CCCEEEEEECCEEEECCCCC------CCCCHHHHHHHHHH
Q ss_conf 488--99602304402658759------------------99489998188125557657------77878899999999
Q gi|254780493|r 8 YIP--ELPNYYSGKVRENYFLS------------------DGTRITIATDRLSAFDQNIA------CIPYKGEVLNQITQ 61 (323)
Q Consensus 8 ~~~--~l~liy~GKvk~vY~~~------------------d~~ll~v~tDriSAfD~~~~------~Ip~KG~~l~~iS~ 61 (323)
+|| .-.-+|+||||+||++. .+.+|||+||||||||++++ +||+||++||+||+
T Consensus 13 ~~p~~~~~~vhsgkvrsvy~l~~~ds~rli~~~~y~~~~d~~l~lmVaSDRISAFD~Vl~~e~~l~gIP~KG~vLn~iS~ 92 (367)
T PRK13960 13 DLPIRTDKPVHSGKVRSVYWLTEEDSRRLIKEKGYNVPADTPLAIMVISDRISAFDCIWHGEGGLKGVPGKGAALNAISN 92 (367)
T ss_pred CCCCCCCCCCCCCCEEEEEECCHHHHHHHHHHCCCCCCCCCCEEEEEECCCCCCEEEEECCCCCCCCCCCCCHHHHHHHH
T ss_conf 87644588754672257885266777789986398889999889999705753015750475657899970599999999
Q ss_pred HHHHHHH--HHCCCCEECCCCCCCCEEEECCCCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 9999854--10233121357763000000254650578852122443220012210247651344663212223568874
Q gi|254780493|r 62 YWFHHTS--DICSNHTLDYPDPNVLVGQQLQMFPIELIVRGYLAGNTKTSLLTFYKNGKRKIYEYLLPDNMSDNQKLPYP 139 (323)
Q Consensus 62 ~~F~~l~--~~i~tH~i~~~~~~~~~v~k~~~iPiE~VvR~y~~GS~~~~~~~~~k~~~~~~~g~~lp~gl~~~~~l~~P 139 (323)
|||++++ ++++||+++.|++.+|+||||+|+|||||||||+|||+| +.|++|.+++||+.||+||+++++||+|
T Consensus 93 fWF~~~~~~~l~~nHild~P~p~v~iVkKakpipIE~VVRGYLTGS~W----reY~kg~r~vCGi~LP~GL~e~qkLpep 168 (367)
T PRK13960 93 HWFKLFKENGLADSHILDIPHPFVWIVQKARPVKIEAICRQYITGSMW----RAYSKGEREFCGITLPEGLEKDQKLPEL 168 (367)
T ss_pred HHHHHCCCCCCCCCCCCCCCCCCEEEEEECCCCEEEEEEEEEECCCCH----HHHHHCCCEEECCCCCCCHHHHCCCCCC
T ss_conf 999744766887763334788634788855552599999851124028----9886178748685667310222459875
Q ss_pred CEEEEEECCCCC-----CCCCCCCCHHHHHHH----HCCCHHHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEEEEE--
Q ss_conf 022321033334-----577755554566653----049989998999999999999999988679788742324455--
Q gi|254780493|r 140 VITPTTKSSESA-----SGCDQPISPNEIIHR----GILTRNQWETISSYALSLFERGCKLALENGLILVDSKYEFGI-- 208 (323)
Q Consensus 140 i~tpstK~~~~~-----~~~D~~i~~~~~~~~----~~~~~~~~~~i~~~sl~i~~~~~~~~~~~GliLvD~K~EFG~-- 208 (323)
|||||||++.++ ..||+||+++++... +.....+++..+.+..+.|+.++++++++|+||||||||||+
T Consensus 169 IfTPSTKA~~~g~~~v~~~hD~nIs~~~i~~~~~~~~~~~~~di~~~e~l~~~~f~~~~~~a~~~GiILaDTKFEFG~~~ 248 (367)
T PRK13960 169 LITPSTKGILTGIPGVPEADDVNISRSDIEANYQAFNFEKAEDIDLYEKLLKEGFKVISKALAKLDQIFVDTKFEFGYVT 248 (367)
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCC
T ss_conf 50788655456887887655565699999998755311139999999999999999999999979938997671277446
Q ss_pred CCCC--CEEEECCCCCCCCCHHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHCCC--------------CCCCCCCCCCH
Q ss_conf 0886--2576200048100000000000123312544443237888765531122--------------36799999898
Q gi|254780493|r 209 DKKQ--NIILADEIHTPDSSRYWEVETYEKSFREGITPIGLDKDFIRNWILTRCN--------------PYRDNIPDIPE 272 (323)
Q Consensus 209 ~~~g--~iiL~DEv~TPDssR~W~~~~ye~~~~~g~~~~s~DKq~~R~wl~~~~~--------------~~~~~~P~LP~ 272 (323)
|.+| +|||+|||+||||||||++++|++ |+.+++ +||.||+||....- ..-.+.|+||+
T Consensus 249 d~~G~~~LILiDEVlTPDSSRfW~ad~Y~~----G~~~en-sKe~FRq~ll~~~~Dpd~llnk~rm~eR~~~a~~~~lP~ 323 (367)
T PRK13960 249 DANGNEKLIYMDEVGTPDSSRIWDGAAYRD----GKIVEN-SKEGFRQFLLNHFPDPDILLNKDRMPEREALARDNALPL 323 (367)
T ss_pred CCCCCEEEEEEECCCCCCCCCCCCHHHCCC----CCCCCC-CCHHHHHHHHHCCCCCCCCCCHHHCCHHHCCCCCCCCCH
T ss_conf 888861699985578887455564321468----865556-558899999853887101246111420111477777989
Q ss_pred HHHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 99999999999999986088664788678999999999999
Q gi|254780493|r 273 NIILRTSQTYIAAYEKITGLKFIADNSELPPLERIRNNLRK 313 (323)
Q Consensus 273 ~vv~~~~~~Y~~~~e~lTG~~f~~~~~~~~~~erI~~~l~~ 313 (323)
+++.++|++|+.+||||||++|+.+. +|.++|.+.|++
T Consensus 324 evv~~~S~~Yi~~~E~ItG~~~~~~~---~P~~~i~~~l~~ 361 (367)
T PRK13960 324 EVMMDVSRTYTGIAEKITGAKIVLSA---NPKAEIIKILRE 361 (367)
T ss_pred HHHHHHHHHHHHHHHHHHCCCCCCCC---CCHHHHHHHHHH
T ss_conf 99999999999999997089655788---858999999997
No 6
>TIGR00081 purC phosphoribosylaminoimidazole-succinocarboxamide synthase; InterPro: IPR001636 Phosphoribosylaminoimidazole-succinocarboxamide synthase (6.3.2.6 from EC) (SAICAR synthetase) catalyzes the seventh step in the de novo purine biosynthetic pathway; the ATP-dependent conversion of 5'-phosphoribosyl-5-aminoimidazole-4-carboxylic acid and aspartic acid to SAICAR . In bacteria (purC), fungi (ADE1) and plants (Pur7), SAICAR synthetase is a monofunctional protein; in animals it is the N-terminal domain of a bifunctional enzyme that also catalyse phosphoribosylaminoimidazole carboxylase (AIRC) activity (see ). ; GO: 0004639 phosphoribosylaminoimidazolesuccinocarboxamide synthase activity, 0006164 purine nucleotide biosynthetic process.
Probab=100.00 E-value=0 Score=544.88 Aligned_cols=275 Identities=29% Similarity=0.429 Sum_probs=252.7
Q ss_pred CCCCCCEEEECCEEEEE----ECCCCCEE-EEEECCEEEEC-CCCC-CCCCHHHHHHHHHHHHHHHHHHH----------
Q ss_conf 48899602304402658----75999489-99818812555-7657-77878899999999999985410----------
Q gi|254780493|r 8 YIPELPNYYSGKVRENY----FLSDGTRI-TIATDRLSAFD-QNIA-CIPYKGEVLNQITQYWFHHTSDI---------- 70 (323)
Q Consensus 8 ~~~~l~liy~GKvk~vY----~~~d~~ll-~v~tDriSAfD-~~~~-~Ip~KG~~l~~iS~~~F~~l~~~---------- 70 (323)
-|-+.++||+||||+|| .+||+.+| ++|+||+|||| +.++ .||+||.+||+||++||+.|+++
T Consensus 22 PIlk~~~lY~GKaK~~YvLke~~dd~~~L~~~f~D~~sAfdYg~~~d~i~~KG~~n~~iS~~~F~~L~~~~~NHl~diaP 101 (374)
T TIGR00081 22 PILKKKLLYSGKAKDLYVLKEETDDPDLLVFVFRDDISAFDYGEKKDQIEGKGRLNTKISAFIFEKLENIVRNHLVDIAP 101 (374)
T ss_pred CCCCCCCCEECCCEEEEEEECCCCCCCEEEEEEEECCCEECCEECCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCC
T ss_conf 41246651003411798850511379778999830531212131368620346899999999999876521444244078
Q ss_pred ------------CCCCEECCCCCCCCEEEECC----------------------------------CCCCEEEEECCCCC
Q ss_conf ------------23312135776300000025----------------------------------46505788521224
Q gi|254780493|r 71 ------------CSNHTLDYPDPNVLVGQQLQ----------------------------------MFPIELIVRGYLAG 104 (323)
Q Consensus 71 ------------i~tH~i~~~~~~~~~v~k~~----------------------------------~iPiE~VvR~y~~G 104 (323)
|||||++.+.++.|+|||++ |||||||||||+||
T Consensus 102 G~~~yD~lPe~Gi~t~y~~~~~~~~~Lvkk~~evenavnemevkLvRvikPknGDYsiFktLkGnF~iPlEvivRN~~aG 181 (374)
T TIGR00081 102 GDSVYDVLPEAGIPTHYIELIEDREMLVKKLDEVENAVNEMEVKLVRVIKPKNGDYSIFKTLKGNFLIPLEVIVRNIAAG 181 (374)
T ss_pred CCEEECCHHHCCCCHHHHHCCCCCEEEEEECHHHHHHHHHEEEEEEEEECCCCCCEEEEEECCCCCCEEEEEEECCCCCC
T ss_conf 87200000101786267523689708998200244224100257899973678871111001577310389996362368
Q ss_pred --CCCCCHHHHHHCCCCCCCC---CCCCCCCCC-CCCCCCCCEEEEEECCCCCCCCCCCCCHHHHHHHHCCCHHHHHHHH
Q ss_conf --4322001221024765134---466321222-3568874022321033334577755554566653049989998999
Q gi|254780493|r 105 --NTKTSLLTFYKNGKRKIYE---YLLPDNMSD-NQKLPYPVITPTTKSSESASGCDQPISPNEIIHRGILTRNQWETIS 178 (323)
Q Consensus 105 --S~~~~~~~~~k~~~~~~~g---~~lp~gl~~-~~~l~~Pi~tpstK~~~~~~~~D~~i~~~~~~~~~~~~~~~~~~i~ 178 (323)
|++++|. ..+++|| +++|+|+.| .++|++++|++|||++. |||++|.+.+.+++++|++++++|+
T Consensus 182 GsS~~kry~-----~tgt~~gDFGl~~~EG~~EL~~pl~e~~~K~S~Kde~----GDp~ln~s~a~~~~~~~~e~~~~~K 252 (374)
T TIGR00081 182 GSSLLKRYE-----RTGTVPGDFGLGLPEGLVELEQPLVEFIFKDSSKDEV----GDPMLNESYAEALGLATEEELERIK 252 (374)
T ss_pred CCCEEEEEC-----CCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCHHHC----CCCCCCHHHHHHHCCCCHHHHHHHH
T ss_conf 842003310-----3783116678883324123277665432388877884----8898887799882367888999999
Q ss_pred HHHHHHHHHHHHHHHHCCCEEEEEEEEEEECCCCCEE-EECCCCCCCCCHHHCCCHHHHHHHCCCCCCCCCHHH-----H
Q ss_conf 9999999999999886797887423244550886257-620004810000000000012331254444323788-----8
Q gi|254780493|r 179 SYALSLFERGCKLALENGLILVDSKYEFGIDKKQNII-LADEIHTPDSSRYWEVETYEKSFREGITPIGLDKDF-----I 252 (323)
Q Consensus 179 ~~sl~i~~~~~~~~~~~GliLvD~K~EFG~~~~g~ii-L~DEv~TPDssR~W~~~~ye~~~~~g~~~~s~DKq~-----~ 252 (323)
++|+++|+.+++++.++||||+|||||||+|..|+++ |+|||+|||+||||+.+++++ |..+.|||||| +
T Consensus 253 ela~~~n~~l~~~~~~~GiIl~DfKlEfG~D~~G~~~iL~DEvlsPD~cRlWd~~t~~~----~~~~~sydkqfeWYDkv 328 (374)
T TIGR00081 253 ELALKVNEVLKRLFDEKGIILVDFKLEFGLDEEGNLIILADEVLSPDTCRLWDKETYES----GELLRSYDKQFEWYDKV 328 (374)
T ss_pred HHHHHHHHHHHHHHHHCCCEECCCCEEEEECCCCEEEEEEEEECCCCCCCCCHHHHHHH----CCCCCHHHHHHHHHHHH
T ss_conf 99999989999999718957105424662037852899974434888521361234321----15761122221267888
Q ss_pred HHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 76553112236799999898999999999999999860886647
Q gi|254780493|r 253 RNWILTRCNPYRDNIPDIPENIILRTSQTYIAAYEKITGLKFIA 296 (323)
Q Consensus 253 R~wl~~~~~~~~~~~P~LP~~vv~~~~~~Y~~~~e~lTG~~f~~ 296 (323)
|||+..++| ..-+.|+||+|++..+...|.++|+.++...+..
T Consensus 329 Rdwl~~~gw-~~v~~pkldkD~frr~~~~~~~AY~~v~~r~~~~ 371 (374)
T TIGR00081 329 RDWLEQEGW-EAVGLPKLDKDIFRRTLGKLIEAYETVAKRLGSQ 371 (374)
T ss_pred HHHHHCCCC-CCCCCCCCCCCCEECCHHHHHHHHHHHHHHHHHH
T ss_conf 877530552-3486466670216747778999999998533221
No 7
>cd01415 SAICAR_synt_PurC bacterial and archaeal 5-aminoimidazole-4-(N-succinylcarboxamide) ribonucleotide (SAICAR) synthase. A subfamily of SAICAR synthetases represented by the Thermotoga maritima (Tm) enzyme and E. coli PurC. SAICAR synthetase catalyzes the seventh step of the de novo biosynthesis of purine nucleotides (also reported as eighth step). It converts 5-aminoimidazole-4-carboxyribonucleotide (CAIR), ATP, and L-aspartate into 5-aminoimidazole-4-(N-succinylcarboxamide) ribonucleotide (SAICAR), ADP, and phosphate.
Probab=100.00 E-value=0 Score=529.17 Aligned_cols=226 Identities=29% Similarity=0.408 Sum_probs=210.8
Q ss_pred EEEECCEEEEEECCCC-CEEEEEECCEEEECCCCC-CCCCHHHHHHHHHHHHHHHHHHH-CCCCEECCCCCCCCEEEECC
Q ss_conf 0230440265875999-489998188125557657-77878899999999999985410-23312135776300000025
Q gi|254780493|r 14 NYYSGKVRENYFLSDG-TRITIATDRLSAFDQNIA-CIPYKGEVLNQITQYWFHHTSDI-CSNHTLDYPDPNVLVGQQLQ 90 (323)
Q Consensus 14 liy~GKvk~vY~~~d~-~ll~v~tDriSAfD~~~~-~Ip~KG~~l~~iS~~~F~~l~~~-i~tH~i~~~~~~~~~v~k~~ 90 (323)
|+|+||||+||+++|+ .++++||||+||||++++ .|||||++||+||+|||++|++. |||||++.+++++|+|+||+
T Consensus 1 Liy~GKvk~iY~~~d~~~li~~~tDriSAfD~~~~~~Ip~KG~il~~iS~~~F~~l~~~gI~tH~i~~~~~~~~~vkk~~ 80 (230)
T cd01415 1 LLYEGKAKIVYATDDPDVLIVEFKDDATAFNGKKKDTIEGKGVLNNEISALIFKYLEENGIKTHFIEKLSDREQLVKKVE 80 (230)
T ss_pred CCCCCCCEEEEECCCCCEEEEEEECCCEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEEEEEE
T ss_conf 96564542789859999999999688152076557889977699999999999988767998202315898559998701
Q ss_pred CCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 46505788521224432200122102476513446632122235688740223210333345777555545666530499
Q gi|254780493|r 91 MFPIELIVRGYLAGNTKTSLLTFYKNGKRKIYEYLLPDNMSDNQKLPYPVITPTTKSSESASGCDQPISPNEIIHRGILT 170 (323)
Q Consensus 91 ~iPiE~VvR~y~~GS~~~~~~~~~k~~~~~~~g~~lp~gl~~~~~l~~Pi~tpstK~~~~~~~~D~~i~~~~~~~~~~~~ 170 (323)
|||+|||||||+|||+|++| |+.+|++||+|+|||+||+++ .|||+||++++.++|+++
T Consensus 81 ~iPiE~VvR~y~tGS~~kry------------------g~~eg~~l~~Pi~e~~~K~d~---~~Dp~i~~~~~~~~~~~~ 139 (230)
T cd01415 81 IIPLEVVVRNIAAGSLVKRL------------------GIEEGTVLDPPIVEFYYKNDE---LGDPLINEDHILALGLAT 139 (230)
T ss_pred EEEEEEEEEEEEEEEEEEEC------------------CCCCCCCCCCCEECCEECCCC---CCCCCCCHHHHHHHCCCC
T ss_conf 45089999767511225324------------------866667999861012321666---789865999999850289
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEEEEECCCCCEEEECCCCCCCCCHHHCCCHHHHHHHCCCCCCCCCHH
Q ss_conf 89998999999999999999988679788742324455088625762000481000000000001233125444432378
Q gi|254780493|r 171 RNQWETISSYALSLFERGCKLALENGLILVDSKYEFGIDKKQNIILADEIHTPDSSRYWEVETYEKSFREGITPIGLDKD 250 (323)
Q Consensus 171 ~~~~~~i~~~sl~i~~~~~~~~~~~GliLvD~K~EFG~~~~g~iiL~DEv~TPDssR~W~~~~ye~~~~~g~~~~s~DKq 250 (323)
++++++++++|+++|+.++++|+++||+|||||||||++.+|+|+|+||| ||||||||++++| ++||||
T Consensus 140 ~~~~~~i~~~al~i~~~~~~~~~~~GliLvD~K~EFG~~~~g~i~L~DEi-tPDssR~W~~~~~----------~~~DKq 208 (230)
T cd01415 140 EEELKEIKELALKINEVLSEFFAEIGIILVDFKLEFGRDKDGEIVLADEI-SPDTCRLWDKETG----------EKLDKD 208 (230)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEEEEECCCCCEEEEEEE-CCCCCCCCCCCCC----------CCCCHH
T ss_conf 99999999999999999999999789889998799878699959999856-7974203508987----------534729
Q ss_pred HHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q ss_conf 8876553112236799999898999999999999999860
Q gi|254780493|r 251 FIRNWILTRCNPYRDNIPDIPENIILRTSQTYIAAYEKIT 290 (323)
Q Consensus 251 ~~R~wl~~~~~~~~~~~P~LP~~vv~~~~~~Y~~~~e~lT 290 (323)
++|+|+. .+.+.|.++++||.
T Consensus 209 ~~R~~~~-------------------~~~~~Y~~v~~r~~ 229 (230)
T cd01415 209 RFRRDLG-------------------DVIEAYEEVLKRLG 229 (230)
T ss_pred HHHCCCC-------------------CHHHHHHHHHHHHC
T ss_conf 8863556-------------------37799999999745
No 8
>PRK09362 phosphoribosylaminoimidazole-succinocarboxamide synthase; Reviewed
Probab=100.00 E-value=0 Score=526.52 Aligned_cols=232 Identities=28% Similarity=0.385 Sum_probs=214.9
Q ss_pred CCCCEEEECCEEEEEECCCC-CEEEEEECCEEEECCCCC-CCCCHHHHHHHHHHHHHHHHHHH-CCCCEECCCCCCCCEE
Q ss_conf 89960230440265875999-489998188125557657-77878899999999999985410-2331213577630000
Q gi|254780493|r 10 PELPNYYSGKVRENYFLSDG-TRITIATDRLSAFDQNIA-CIPYKGEVLNQITQYWFHHTSDI-CSNHTLDYPDPNVLVG 86 (323)
Q Consensus 10 ~~l~liy~GKvk~vY~~~d~-~ll~v~tDriSAfD~~~~-~Ip~KG~~l~~iS~~~F~~l~~~-i~tH~i~~~~~~~~~v 86 (323)
...+++|+||||+||+++|+ .++++||||+||||++++ .|||||++||+||+|||++|+++ ||||||+.+++++|+|
T Consensus 2 ~~~~lly~GKvk~vY~~~d~~~li~~~~DriSAfD~~~~~~IpgKG~~l~~iS~~~F~~l~~~GI~tH~i~~~~~~~m~v 81 (238)
T PRK09362 2 EKKELLYEGKAKIVYSTDDPDLLILEFKDDATAFNGEKKEQIDGKGVLNNQISAFIFKKLEEAGIPTHFIEKLSDREQLV 81 (238)
T ss_pred CCCCEEEECCCEEEEECCCCCEEEEEEECCCEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEE
T ss_conf 86763664167478885999999999968825207555788997669999999999998746799805541479835999
Q ss_pred EECCCCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCHHHHHHH
Q ss_conf 00254650578852122443220012210247651344663212223568874022321033334577755554566653
Q gi|254780493|r 87 QQLQMFPIELIVRGYLAGNTKTSLLTFYKNGKRKIYEYLLPDNMSDNQKLPYPVITPTTKSSESASGCDQPISPNEIIHR 166 (323)
Q Consensus 87 ~k~~~iPiE~VvR~y~~GS~~~~~~~~~k~~~~~~~g~~lp~gl~~~~~l~~Pi~tpstK~~~~~~~~D~~i~~~~~~~~ 166 (323)
+||+|||+|||||||+|||++++| |+.+|++||+|++||+||+++ .|||+|+++++.++
T Consensus 82 kk~~~iPiE~VvR~y~~GS~~~r~------------------g~~eg~~l~~Pi~e~~~K~d~---~~Dp~i~~~~~~~~ 140 (238)
T PRK09362 82 KKVEIIPLEVVVRNVAAGSLVKRL------------------GIEEGTVLPPPIVEFYYKNDA---LGDPMINEDHILAL 140 (238)
T ss_pred EEEEEEEEEEEEEEEEEEEEECCC------------------CCCCCCCCCCCEEECEECCCC---CCCCCCCHHHHHHH
T ss_conf 970245089999525750440125------------------864476789871202335666---78997599999985
Q ss_pred HCCCHHHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEEEEECCCCCEEEECCCCCCCCCHHHCCCHHHHHHHCCCCCCC
Q ss_conf 04998999899999999999999998867978874232445508862576200048100000000000123312544443
Q gi|254780493|r 167 GILTRNQWETISSYALSLFERGCKLALENGLILVDSKYEFGIDKKQNIILADEIHTPDSSRYWEVETYEKSFREGITPIG 246 (323)
Q Consensus 167 ~~~~~~~~~~i~~~sl~i~~~~~~~~~~~GliLvD~K~EFG~~~~g~iiL~DEv~TPDssR~W~~~~ye~~~~~g~~~~s 246 (323)
|++++++++++++.|+++|+.++++|+++||+|||||||||++.+|+|+|+||| ||||||||++++|+ +
T Consensus 141 ~~~~~~~~~~i~~~al~i~~~~~~~~~~~GliLvD~K~EFG~~~~g~i~L~DEi-TPDs~R~W~~~~~~----------~ 209 (238)
T PRK09362 141 GWATPEELAEIKELALKINDVLKGLFAGIGIRLVDFKLEFGRDFDGEIVLADEI-SPDTCRLWDKETNE----------K 209 (238)
T ss_pred HCCCHHHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEEEEECCCCCEEEEEEE-CCCCCCCCCCCCCC----------C
T ss_conf 028999999999999999999999999789889998799878599989999855-79853035188876----------2
Q ss_pred CCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC
Q ss_conf 2378887655311223679999989899999999999999986088
Q gi|254780493|r 247 LDKDFIRNWILTRCNPYRDNIPDIPENIILRTSQTYIAAYEKITGL 292 (323)
Q Consensus 247 ~DKq~~R~wl~~~~~~~~~~~P~LP~~vv~~~~~~Y~~~~e~lTG~ 292 (323)
||||++|+|+. .+.+.|.++++||-..
T Consensus 210 lDK~~~R~~l~-------------------~~~~~Y~~v~~r~~~~ 236 (238)
T PRK09362 210 LDKDRFRRDLG-------------------GVIEAYEEVLKRLGEL 236 (238)
T ss_pred CCHHHHHCCCC-------------------CHHHHHHHHHHHHHCC
T ss_conf 46698860345-------------------3889999999987343
No 9
>pfam01259 SAICAR_synt SAICAR synthetase. Also known as Phosphoribosylaminoimidazole-succinocarboxamide synthase.
Probab=100.00 E-value=0 Score=526.27 Aligned_cols=240 Identities=36% Similarity=0.634 Sum_probs=224.8
Q ss_pred CCCEEEECCEEEEEECCCC-CEEEEEECCEEEECCCCC-CCCCHHHHHHHHHHHHHHHHHHH-CCCCEECCCCCCCCEEE
Q ss_conf 9960230440265875999-489998188125557657-77878899999999999985410-23312135776300000
Q gi|254780493|r 11 ELPNYYSGKVRENYFLSDG-TRITIATDRLSAFDQNIA-CIPYKGEVLNQITQYWFHHTSDI-CSNHTLDYPDPNVLVGQ 87 (323)
Q Consensus 11 ~l~liy~GKvk~vY~~~d~-~ll~v~tDriSAfD~~~~-~Ip~KG~~l~~iS~~~F~~l~~~-i~tH~i~~~~~~~~~v~ 87 (323)
+++++|+||||+||+++|+ .++|+||||+||||++++ .|||||++||+||+|||++|+++ |+||||+.+++++|+|+
T Consensus 1 kl~lly~GKvK~vy~~~d~~~ll~~f~DriSafD~~~~~~IpgKG~~l~~iS~~~F~~l~~~GI~tH~i~~~~~~~~~vk 80 (243)
T pfam01259 1 KLPLLARGKVKDIYETDDENTLLMVAKDRISAFDGIRKNQIPGKGRILNKTSSFWFEFLQEAGIPNHFVESLSETELLVK 80 (243)
T ss_pred CCCCEECCCCEEEEECCCCCEEEEEEECCCEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHCCCCHHHHCCCCCCEEEEE
T ss_conf 98312213674889859999999999798672186057899977799999999999988665983655068999618887
Q ss_pred ECCCCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCHHHHHHHH
Q ss_conf 02546505788521224432200122102476513446632122235688740223210333345777555545666530
Q gi|254780493|r 88 QLQMFPIELIVRGYLAGNTKTSLLTFYKNGKRKIYEYLLPDNMSDNQKLPYPVITPTTKSSESASGCDQPISPNEIIHRG 167 (323)
Q Consensus 88 k~~~iPiE~VvR~y~~GS~~~~~~~~~k~~~~~~~g~~lp~gl~~~~~l~~Pi~tpstK~~~~~~~~D~~i~~~~~~~~~ 167 (323)
+|+|||||||||||+|||+|++|. +..||..+|+++.+.+.+++|++||+||++ ||.+++.+++. .
T Consensus 81 k~~~iPlEvIvR~y~~GS~~~ry~-------g~~~G~~l~~~l~e~~~k~d~~~dP~~k~e-----~d~~l~~~~~~--~ 146 (243)
T pfam01259 81 KLKMIPIEVVVRGYATGSFLKRYT-------GVVEGIKLPPGLVESFYKPDAIFDPSTKAE-----HDENISFAQAE--L 146 (243)
T ss_pred EECCCCEEEEEEEEEECHHEEECC-------CCCCCCCCCCCHHHHHCCCCCCCCCCCCHH-----HHHHCCHHHHH--H
T ss_conf 402565699998687121102317-------973687489544665426522368846899-----99858985754--2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEEEEECCCCCEEEECCCCCCCCCHHHCCCHHHHHHHCCCCCCCC
Q ss_conf 49989998999999999999999988679788742324455088625762000481000000000001233125444432
Q gi|254780493|r 168 ILTRNQWETISSYALSLFERGCKLALENGLILVDSKYEFGIDKKQNIILADEIHTPDSSRYWEVETYEKSFREGITPIGL 247 (323)
Q Consensus 168 ~~~~~~~~~i~~~sl~i~~~~~~~~~~~GliLvD~K~EFG~~~~g~iiL~DEv~TPDssR~W~~~~ye~~~~~g~~~~s~ 247 (323)
+++.++++.|++.|+++|+.++++|+++||+|||||||||++.+|+|+|+||| +|||||||++++|+ .++
T Consensus 147 ~~~~ee~~~i~~~al~i~~~l~~~~~~~Gl~LvD~K~EFG~~~~g~ivL~DEI-~PDs~R~Wd~~~~~---------~~l 216 (243)
T pfam01259 147 LVGKEEADRMKEKTLALYEKLKKYAADKGIILVDTKFEFGLDKDGEILLADEI-SPDSSRLWDADTYE---------KQY 216 (243)
T ss_pred HCCHHHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEEEEECCCCCEEEEEEE-CCCCCCCEECCCCC---------CCC
T ss_conf 15999999999999999999999999789889997789867699959999866-79744331688886---------046
Q ss_pred CHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 378887655311223679999989899
Q gi|254780493|r 248 DKDFIRNWILTRCNPYRDNIPDIPENI 274 (323)
Q Consensus 248 DKq~~R~wl~~~~~~~~~~~P~LP~~v 274 (323)
|||++|+|+...+|.+++++|.||++|
T Consensus 217 DK~~~R~~l~~~~~~y~~v~~~l~~~~ 243 (243)
T pfam01259 217 DKQFLRDWLGSNGEAYEEVGPKLPEDI 243 (243)
T ss_pred CHHHHHHHCCCCCCCCCCCCCCCCCCC
T ss_conf 829887240046606674665587559
No 10
>cd01416 SAICAR_synt_Ade5 Ade5_like 5-aminoimidazole-4-(N-succinylcarboxamide) ribonucleotide (SAICAR) synthase. Eukaryotic group of SAICAR synthetases represented by the Drosophila melanogaster, N-terminal, SAICAR synthetase domain of bifunctional Ade5. The Ade5 gene product (CAIR-SAICARs) catalyzes the sixth and seventh steps of the de novo biosynthesis of purine nucleotides (also reported as seventh and eighth steps). SAICAR synthetase converts 5-aminoimidazole-4-carboxyribonucleotide (CAIR), ATP, and L-aspartate into 5-aminoimidazole-4-(N-succinylcarboxamide) ribonucleotide (SAICAR), ADP, and phosphate.
Probab=100.00 E-value=0 Score=513.31 Aligned_cols=237 Identities=23% Similarity=0.316 Sum_probs=215.7
Q ss_pred CCCEEEECCEEEEEECCC--CCEEEEEECCEEEECCCCC-CCCCHHHHHHHHHHHHHHHHHHH-CCCCEECCCCCCCCEE
Q ss_conf 996023044026587599--9489998188125557657-77878899999999999985410-2331213577630000
Q gi|254780493|r 11 ELPNYYSGKVRENYFLSD--GTRITIATDRLSAFDQNIA-CIPYKGEVLNQITQYWFHHTSDI-CSNHTLDYPDPNVLVG 86 (323)
Q Consensus 11 ~l~liy~GKvk~vY~~~d--~~ll~v~tDriSAfD~~~~-~Ip~KG~~l~~iS~~~F~~l~~~-i~tH~i~~~~~~~~~v 86 (323)
.-+++|+||||+||+++| +.+|+++|||+||||++++ .|||||++||+||+|||++|+++ |||||++.+++++|+|
T Consensus 3 ~~k~ly~GKvk~vY~~~d~~~~lli~~tDriSAfD~~~~~~IpgKG~~l~~iS~~~F~~l~~~gI~tH~i~~~~~~~~lv 82 (252)
T cd01416 3 LGKKLIEGKTKIVYELPDQPGLVLIQSKDRITAGDGARKDEIEGKAAISNKTTSNVFELLQEAGIKTHFVKQCSPTAFIA 82 (252)
T ss_pred CCCEEECCCCEEEEECCCCCCEEEEEEECCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCHHCCCCCCCEEEE
T ss_conf 88843314575886458999889999978972327605788897869999999999988620799801216899804777
Q ss_pred EECCCCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCHHHHHHH
Q ss_conf 00254650578852122443220012210247651344663212223568874022321033334577755554566653
Q gi|254780493|r 87 QQLQMFPIELIVRGYLAGNTKTSLLTFYKNGKRKIYEYLLPDNMSDNQKLPYPVITPTTKSSESASGCDQPISPNEIIHR 166 (323)
Q Consensus 87 ~k~~~iPiE~VvR~y~~GS~~~~~~~~~k~~~~~~~g~~lp~gl~~~~~l~~Pi~tpstK~~~~~~~~D~~i~~~~~~~~ 166 (323)
|||+|||||||||||+|||++++| .|+.+|++|++|++||++|++. .|||+|++++++++
T Consensus 83 kk~~~iPiE~VVR~ya~GS~~kr~-----------------~g~~eg~~l~~pl~e~~~K~d~---~~Dp~it~~~i~~~ 142 (252)
T cd01416 83 RKCEMIPIEWVCRRIATGSFLKRN-----------------PGVKEGYRFSPPKLEFFYKDDA---NHDPQWSEEQLLEA 142 (252)
T ss_pred EECCCCCEEEEEEEEEECCCCCCC-----------------CCCCCCCCCCCCCCCCCCCCCC---CCCCCCCHHHHHHC
T ss_conf 614630579999620344412136-----------------8987746289763444246656---78998899999867
Q ss_pred HC------CCHHHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEEEEECCC-CCEEEECCCCCCCCCHHHCCCHHHHHHH
Q ss_conf 04------9989998999999999999999988679788742324455088-6257620004810000000000012331
Q gi|254780493|r 167 GI------LTRNQWETISSYALSLFERGCKLALENGLILVDSKYEFGIDKK-QNIILADEIHTPDSSRYWEVETYEKSFR 239 (323)
Q Consensus 167 ~~------~~~~~~~~i~~~sl~i~~~~~~~~~~~GliLvD~K~EFG~~~~-g~iiL~DEv~TPDssR~W~~~~ye~~~~ 239 (323)
++ +|.++++++++.|+++|+.++++|.++||+|||||||||++.+ |+|+|+||+ |||||||||+
T Consensus 143 ~~~~~~~~~~~~~~~~i~~~al~i~~~l~~~~~~~GiiLvDtK~EFG~d~~~g~ivl~D~i-tPDSsR~W~~-------- 213 (252)
T cd01416 143 KLNCGGLKIGKKEVDIMTKSTIAIFEILEKAWATQDCTLVDMKIEFGVDVTTGEILLADVI-DNDSWRLWPS-------- 213 (252)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEEEEEECCCCEEEEEEEE-CCCCCCCCCC--------
T ss_conf 8530134489999999999999999999999997898899617886464789979999800-7986441648--------
Q ss_pred CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q ss_conf 25444432378887655311223679999989899999999999999986
Q gi|254780493|r 240 EGITPIGLDKDFIRNWILTRCNPYRDNIPDIPENIILRTSQTYIAAYEKI 289 (323)
Q Consensus 240 ~g~~~~s~DKq~~R~wl~~~~~~~~~~~P~LP~~vv~~~~~~Y~~~~e~l 289 (323)
|..+.++|||++|||+. .-++-...+.++|.++++||
T Consensus 214 -~~~~~~~DK~~~Rd~~~------------~~~~~~~~v~~~~~~v~~rl 250 (252)
T cd01416 214 -GDKRLMKDKQVYRNLKE------------VTDEALQEVKKNYEWVADKL 250 (252)
T ss_pred -CCCCCCCCCHHHCCCCC------------CHHHHHHHHHHHHHHHHHHH
T ss_conf -99771644441006764------------42999999999999999986
No 11
>COG0152 PurC Phosphoribosylaminoimidazolesuccinocarboxamide (SAICAR) synthase [Nucleotide transport and metabolism]
Probab=100.00 E-value=0 Score=512.56 Aligned_cols=242 Identities=38% Similarity=0.573 Sum_probs=221.2
Q ss_pred CCCEEEECCEEEEEECCCCC-EEEEEECCEEEECCCCCC-CCCHHHHHHHHHHHHHHHHHH-HCCCCEECCCCCCCCEEE
Q ss_conf 99602304402658759994-899981881255576577-787889999999999998541-023312135776300000
Q gi|254780493|r 11 ELPNYYSGKVRENYFLSDGT-RITIATDRLSAFDQNIAC-IPYKGEVLNQITQYWFHHTSD-ICSNHTLDYPDPNVLVGQ 87 (323)
Q Consensus 11 ~l~liy~GKvk~vY~~~d~~-ll~v~tDriSAfD~~~~~-Ip~KG~~l~~iS~~~F~~l~~-~i~tH~i~~~~~~~~~v~ 87 (323)
...++|+||||++|+++|+. ++|+||||+||||+++++ |||||++||+||+|||++|++ +|||||++.+++++++|+
T Consensus 3 ~~~~ly~GKaK~vY~~~d~~~li~~f~D~~sAfdg~~~~~i~gKG~~n~~iS~~~F~~L~~~gi~tH~i~~~~~~~~lvk 82 (247)
T COG0152 3 KLRLLYEGKAKDLYETDDPDLLIMEFSDRASAFDGEKKDQIPGKGALNNQISAFIFEKLEEAGIPTHFIELLSDREQLVK 82 (247)
T ss_pred CCCCCCCCCCCEEEECCCCCEEEEEEECCCEECCCCCCCCCCCHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCEEEEE
T ss_conf 64311044331236759988899999546320253215667870699999999999999874997305311699748888
Q ss_pred ECCCCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCHHHHHHHH
Q ss_conf 02546505788521224432200122102476513446632122235688740223210333345777555545666530
Q gi|254780493|r 88 QLQMFPIELIVRGYLAGNTKTSLLTFYKNGKRKIYEYLLPDNMSDNQKLPYPVITPTTKSSESASGCDQPISPNEIIHRG 167 (323)
Q Consensus 88 k~~~iPiE~VvR~y~~GS~~~~~~~~~k~~~~~~~g~~lp~gl~~~~~l~~Pi~tpstK~~~~~~~~D~~i~~~~~~~~~ 167 (323)
+++|||||||||||+|||++++| ..+++++|+.++++++.++++|++|+|| |.+|+ ..+
T Consensus 83 k~~iiPlEvVvRn~~aGS~~kr~----~~~eg~~~~~~l~e~~~k~d~l~dPiv~------------d~~i~-----~~~ 141 (247)
T COG0152 83 KLEIIPLEVVVRNYAAGSLLKRY----GIEEGTVLGIPLVEFLYKNDELPDPIVT------------DEHIS-----ALG 141 (247)
T ss_pred EEEEEEEEEEEECEECCHHHHHH----CCCCCEECCCCCCCCCCCCCCCCCCCCC------------HHHCC-----HHC
T ss_conf 62487589999530022467761----6666618898874100151004997204------------51345-----203
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEEEEECCCCCEEEECCCCCCCCCHHHCCCHHHHHHHCCCCCCCC
Q ss_conf 49989998999999999999999988679788742324455088625762000481000000000001233125444432
Q gi|254780493|r 168 ILTRNQWETISSYALSLFERGCKLALENGLILVDSKYEFGIDKKQNIILADEIHTPDSSRYWEVETYEKSFREGITPIGL 247 (323)
Q Consensus 168 ~~~~~~~~~i~~~sl~i~~~~~~~~~~~GliLvD~K~EFG~~~~g~iiL~DEv~TPDssR~W~~~~ye~~~~~g~~~~s~ 247 (323)
+++++++++|+++++++|+.++++++++||+|||||||||++.+|+|+|+|||. |||||||++++|++ +|
T Consensus 142 ~~~~ee~~~i~~~alkin~~l~~~~~~~GiilvD~KlEFG~d~~g~iiLaDEis-PDs~R~Wd~~t~~~---------~~ 211 (247)
T COG0152 142 IATPEEIEEIKELALKINEVLKDLFAKRGIILVDFKLEFGLDEDGEIVLADEIS-PDSCRLWDAETYEK---------SL 211 (247)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEEEEECCCCCEEEEEEEC-CCCCCCCCCCCCCC---------CC
T ss_conf 489999999999999999999999985896797666886675999889984337-97544664654643---------12
Q ss_pred CHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHC
Q ss_conf 37888765531122367999998989999999999999998608
Q gi|254780493|r 248 DKDFIRNWILTRCNPYRDNIPDIPENIILRTSQTYIAAYEKITG 291 (323)
Q Consensus 248 DKq~~R~wl~~~~~~~~~~~P~LP~~vv~~~~~~Y~~~~e~lTG 291 (323)
|||++|+++. ++|++|++|++.++..|.++|+++||
T Consensus 212 DKd~~R~~~g--------~~~~~y~ev~~r~~~~~~~~~~~itg 247 (247)
T COG0152 212 DKDFFRRDLG--------DLPELYEEVLERLSDLYEEAYERITG 247 (247)
T ss_pred CHHHHHHCCC--------CCCCCHHHHHHHHHHHHHHHHHHCCC
T ss_conf 4678751379--------85404999999999999988875059
No 12
>cd00476 SAICAR_synt 5-aminoimidazole-4-(N-succinylcarboxamide) ribonucleotide (SAICAR) synthase. SAICAR synthetase (the PurC gene product) catalyzes the seventh step of the de novo biosynthesis of purine nucleotides (also reported as eighth step). It converts 5-aminoimidazole-4-carboxyribonucleotide (CAIR), ATP, and L-aspartate into 5-aminoimidazole-4-(N-succinylcarboxamide) ribonucleotide (SAICAR), ADP, and phosphate.
Probab=100.00 E-value=0 Score=498.04 Aligned_cols=228 Identities=26% Similarity=0.389 Sum_probs=208.8
Q ss_pred EEEECCEEEEEECCCCCEEEEEECCEEEECCCCC-CCCCHHHHHHHHHHHHHHHHHHH-CCCCEECCCCCCCCEEEECCC
Q ss_conf 0230440265875999489998188125557657-77878899999999999985410-233121357763000000254
Q gi|254780493|r 14 NYYSGKVRENYFLSDGTRITIATDRLSAFDQNIA-CIPYKGEVLNQITQYWFHHTSDI-CSNHTLDYPDPNVLVGQQLQM 91 (323)
Q Consensus 14 liy~GKvk~vY~~~d~~ll~v~tDriSAfD~~~~-~Ip~KG~~l~~iS~~~F~~l~~~-i~tH~i~~~~~~~~~v~k~~~ 91 (323)
.+|+||||+||+++++.++++||||+||||++++ .|||||++||+||+|||++|+++ |||||++.+++++|+|++|+|
T Consensus 1 ~lY~GK~K~vy~~~~~~ll~~~~DriSafD~~~~~~i~gKG~~~~~iS~~~F~~l~~~GI~tH~i~~~~~~~~~vkk~~~ 80 (230)
T cd00476 1 TLYRGKTKIVYETKDGVLLLEFKDDISAGDGARRNFLDEKGDITAKLTLFIFKYLSEAGIPTHFVERLGPRTLLVDKLKX 80 (230)
T ss_pred CCCCCCCEEEEECCCCEEEEEEECCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCHHHHCCCCCCEEEEEECCE
T ss_conf 95302352789769998999997985142763678899878999999999999862169973564369994799998876
Q ss_pred CCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCHHHHHHHHCCCH
Q ss_conf 65057885212244322001221024765134466321222356887402232103333457775555456665304998
Q gi|254780493|r 92 FPIELIVRGYLAGNTKTSLLTFYKNGKRKIYEYLLPDNMSDNQKLPYPVITPTTKSSESASGCDQPISPNEIIHRGILTR 171 (323)
Q Consensus 92 iPiE~VvR~y~~GS~~~~~~~~~k~~~~~~~g~~lp~gl~~~~~l~~Pi~tpstK~~~~~~~~D~~i~~~~~~~~~~~~~ 171 (323)
||||||||||+|||+|++|. |+.++++||+|+|||+||+|. .|||+|+++++.+++++++
T Consensus 81 iplEvVvR~ya~GS~~rry~-----------------g~~eg~~l~~Pi~e~~~K~d~---~~Dp~i~~~~~~~~~~~~~ 140 (230)
T cd00476 81 IPLEVVVRNRATGSFVKRYG-----------------GFKEGREFPPPLVEFFYKDDA---EHDPIVSEDQLERLGFIGK 140 (230)
T ss_pred EEEEEEEEEEECCCHHHHCC-----------------CCCCCCCCCCCEEEEEECCCC---CCCCCCCHHHHHHHCCCCH
T ss_conf 45799997112020576617-----------------875776189866787733787---8999889999998568999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEEEEECCCCCEEEECCCCCCCCCHHHCCCHHHHHHHCCCCCCCCCHHH
Q ss_conf 99989999999999999999886797887423244550886257620004810000000000012331254444323788
Q gi|254780493|r 172 NQWETISSYALSLFERGCKLALENGLILVDSKYEFGIDKKQNIILADEIHTPDSSRYWEVETYEKSFREGITPIGLDKDF 251 (323)
Q Consensus 172 ~~~~~i~~~sl~i~~~~~~~~~~~GliLvD~K~EFG~~~~g~iiL~DEv~TPDssR~W~~~~ye~~~~~g~~~~s~DKq~ 251 (323)
+++++|++.|+++|+.++++|+++||+|||||||||++.+|+|+|+||| |||||||||+++| ++|||.
T Consensus 141 ~e~~~i~~~al~v~~~l~~~~~~~Gl~LVD~K~EFG~~~~G~ivL~DEi-sPDs~R~Wd~~~~-----------~~~kd~ 208 (230)
T cd00476 141 VDVERXKELAVKINTVLKKLFSPAGLELWDFKLEFGLDEEGEIVLGDEI-SPDSSRLWRKGGE-----------PYDKDL 208 (230)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEEEEECCCCCEEEEEEE-CCCCCCCCCCCCC-----------CCCCHH
T ss_conf 9999999999999999999999789989998899878799989999970-8986433228986-----------000103
Q ss_pred HHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q ss_conf 876553112236799999898999999999999999860
Q gi|254780493|r 252 IRNWILTRCNPYRDNIPDIPENIILRTSQTYIAAYEKIT 290 (323)
Q Consensus 252 ~R~wl~~~~~~~~~~~P~LP~~vv~~~~~~Y~~~~e~lT 290 (323)
.|.. .-+..+.+.|.++++||.
T Consensus 209 ~r~~-----------------~~l~~~~~~Y~ev~~rl~ 230 (230)
T cd00476 209 FRRR-----------------ASLGQIIEKYEEVAELVR 230 (230)
T ss_pred HHHC-----------------CCCHHHHHHHHHHHHHHC
T ss_conf 4302-----------------651769999999999759
No 13
>TIGR02735 purC_vibrio phosphoribosylaminoimidazole-succinocarboxamide synthase; InterPro: IPR014106 Members of this protein family appear to represent a novel form of phosphoribosylaminoimidazole-succinocarboxamide synthase (SAICAR synthetase), significantly different in sequence from (IPR001636 from INTERPRO), which is found in a broad range of bacteria and eukaryotes. Members of this family are found within the gammaproteobacteria in the genera Vibrio, Shewanella, and Colwellia, and also (reported as a fragment) in the primitive eukaryote Guillardia theta (Cryptomonas phi)..
Probab=100.00 E-value=0 Score=459.21 Aligned_cols=294 Identities=31% Similarity=0.457 Sum_probs=244.9
Q ss_pred CCCCCCEEEECCEEEEEECC--CC----------------CEEEEEECCEEEECCC------CCCCCCHHHHHHHHHHHH
Q ss_conf 48899602304402658759--99----------------4899981881255576------577787889999999999
Q gi|254780493|r 8 YIPELPNYYSGKVRENYFLS--DG----------------TRITIATDRLSAFDQN------IACIPYKGEVLNQITQYW 63 (323)
Q Consensus 8 ~~~~l~liy~GKvk~vY~~~--d~----------------~ll~v~tDriSAfD~~------~~~Ip~KG~~l~~iS~~~ 63 (323)
.++.-+-+|+||||+||++. |. .-+||.||||||||++ ++++||||++||+||.+|
T Consensus 14 ~i~Td~~VHSGKVRSVYWL~~~DSRRLI~~k~Y~Va~DA~LAI~viSDR~SAFDCIW~aEGG~~GVPGKGAALNAiS~~W 93 (365)
T TIGR02735 14 PIRTDEPVHSGKVRSVYWLTEEDSRRLIEEKGYPVAEDAPLAILVISDRISAFDCIWHAEGGLKGVPGKGAALNAISNHW 93 (365)
T ss_pred CCCCCCCCCCCCEEEEEECCCHHHHHHHHHCCCCCCCCCCEEEEEEECHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH
T ss_conf 88888852356301465158023578886368888877550466533100033300014787336686207888888999
Q ss_pred HHHHH--HHCCCCEECCCCCCCCEEEECCCCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCE
Q ss_conf 99854--1023312135776300000025465057885212244322001221024765134466321222356887402
Q gi|254780493|r 64 FHHTS--DICSNHTLDYPDPNVLVGQQLQMFPIELIVRGYLAGNTKTSLLTFYKNGKRKIYEYLLPDNMSDNQKLPYPVI 141 (323)
Q Consensus 64 F~~l~--~~i~tH~i~~~~~~~~~v~k~~~iPiE~VvR~y~~GS~~~~~~~~~k~~~~~~~g~~lp~gl~~~~~l~~Pi~ 141 (323)
|+.++ +....|+++.|+|-+++|+|++|+.||.|||.|+|||. |+.|.+|+|.+||+.+|+||.++++||+-++
T Consensus 94 F~~F~~~gLA~SHIL~~PHP~vWiVQkAkPv~IEAI~RQYITGS~----WRaYaKGER~FCG~~lP~~L~~~~~LpElLi 169 (365)
T TIGR02735 94 FKLFKEAGLAESHILDIPHPFVWIVQKAKPVKIEAICRQYITGSL----WRAYAKGEREFCGIDLPEGLEKDQRLPELLI 169 (365)
T ss_pred HHHHHHCCCCHHHHCCCCCCEEEEEECCCCEEEEEEHHHHHHHHH----HHHHCCCCCCCCCCCCCHHHHHHCCCCCEEE
T ss_conf 999874574001001589871898743762143000001232334----5421156643467755212343056882676
Q ss_pred EEEEECCCC-C----CCCCCCCCHHHHH----HHHCCCHHHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEEEEE----
Q ss_conf 232103333-4----5777555545666----53049989998999999999999999988679788742324455----
Q gi|254780493|r 142 TPTTKSSES-A----SGCDQPISPNEII----HRGILTRNQWETISSYALSLFERGCKLALENGLILVDSKYEFGI---- 208 (323)
Q Consensus 142 tpstK~~~~-~----~~~D~~i~~~~~~----~~~~~~~~~~~~i~~~sl~i~~~~~~~~~~~GliLvD~K~EFG~---- 208 (323)
|||||+-.. . +-.|-|||..++. +++.-.+++.++.+.+-..-|..+.+.+.+.|-+.||||||||.
T Consensus 170 TPS~KGiL~G~~Gv~~~DDVNItR~dIE~~~~~~~F~~p~DIdHYE~LL~~GF~VIs~~L~~lgQlFVDTKFEFGY~td~ 249 (365)
T TIGR02735 170 TPSTKGILEGIPGVPAIDDVNITRKDIERNYSAFNFEQPEDIDHYERLLREGFAVISDRLSKLGQLFVDTKFEFGYVTDV 249 (365)
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEECCEEECC
T ss_conf 68762101578886442444466788998999707898631268999986258999987732674365400101011167
Q ss_pred CCCCCEEEECCCCCCCCCHHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHH--------------CCCCCCCCCCCCCHHH
Q ss_conf 08862576200048100000000000123312544443237888765531--------------1223679999989899
Q gi|254780493|r 209 DKKQNIILADEIHTPDSSRYWEVETYEKSFREGITPIGLDKDFIRNWILT--------------RCNPYRDNIPDIPENI 274 (323)
Q Consensus 209 ~~~g~iiL~DEv~TPDssR~W~~~~ye~~~~~g~~~~s~DKq~~R~wl~~--------------~~~~~~~~~P~LP~~v 274 (323)
.+..+||.+||||||||||+|+|.+|..|..... +|+-||+.|.+ .+...-..--.||+++
T Consensus 250 ~G~~~LIYMDEVGTPDSSRIW~A~~Y~~G~i~EN-----SKEgFRQ~LlN~~PD~~~LL~K~RM~ER~AlA~~~~LP~~~ 324 (365)
T TIGR02735 250 EGKRKLIYMDEVGTPDSSRIWDAGAYAQGKIVEN-----SKEGFRQLLLNYFPDPDILLNKDRMVERAALARDNALPQEV 324 (365)
T ss_pred CCCEEEEEEECCCCCCCHHHHCHHHCCCCCEEEC-----CCCHHHHHHHHCCCCHHHHCCCCCCHHHHHHHCCCCCHHHH
T ss_conf 7762336751468886012212441058827752-----75026888864078722202555405788752155574899
Q ss_pred HHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 999999999999986088664788678999999999999
Q gi|254780493|r 275 ILRTSQTYIAAYEKITGLKFIADNSELPPLERIRNNLRK 313 (323)
Q Consensus 275 v~~~~~~Y~~~~e~lTG~~f~~~~~~~~~~erI~~~l~~ 313 (323)
+.++|+.|..++++|||++...+.. |..+|..-|++
T Consensus 325 L~dvS~~YlgIA~~I~G~~I~l~~~---Pk~EI~~~L~~ 360 (365)
T TIGR02735 325 LLDVSKTYLGIAEKITGKSITLSEN---PKAEIKAILSK 360 (365)
T ss_pred HHHHHHHHHHHHHHHCCCCEEECCC---CHHHHHHHHHH
T ss_conf 9999999998776634870120767---36899999875
No 14
>KOG2835 consensus
Probab=100.00 E-value=8.7e-40 Score=273.46 Aligned_cols=306 Identities=23% Similarity=0.215 Sum_probs=257.5
Q ss_pred CCCCCCCC-CCEEEECCEEEEEECCC--CCEEEEEECCEEEECCCCC-CCCCHHHHHHHHHHHHHHHHHH-HCCCCEECC
Q ss_conf 00054889-96023044026587599--9489998188125557657-7787889999999999998541-023312135
Q gi|254780493|r 4 LSKAYIPE-LPNYYSGKVRENYFLSD--GTRITIATDRLSAFDQNIA-CIPYKGEVLNQITQYWFHHTSD-ICSNHTLDY 78 (323)
Q Consensus 4 l~~~~~~~-l~liy~GKvk~vY~~~d--~~ll~v~tDriSAfD~~~~-~Ip~KG~~l~~iS~~~F~~l~~-~i~tH~i~~ 78 (323)
+..+.+.. .+++++||||++|.+.+ +.++++.+|||||||.+++ .|++||+++++++.+||+.++. .++++|.+.
T Consensus 3 l~~~~~~~~~k~la~gkvr~v~~~~~~~~~vlti~kD~I~a~~~~~a~~I~~ka~il~k~t~~~F~~l~~~gv~~~~~~~ 82 (373)
T KOG2835 3 LTTESLDPLGKELAEGKVRDVYELVDSPGLVLTISKDRITALDAAMANSIQGKAAILNKITSFVFELLGEAGIETAFTEQ 82 (373)
T ss_pred CCCCCCCCHHHHHHEEEEEEECCCCCCCCEEEEEECCCCCHHHHHHHCCHHHHHHHHHHHHHHHHHHHHHHHHHEEECCC
T ss_conf 41112242132343454421024566887367765054103444542012567789887666667654032012111034
Q ss_pred C---------------------CCCCCEEEECCCCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCC-----CCCCCCCCC
Q ss_conf 7---------------------76300000025465057885212244322001221024765134-----466321222
Q gi|254780493|r 79 P---------------------DPNVLVGQQLQMFPIELIVRGYLAGNTKTSLLTFYKNGKRKIYE-----YLLPDNMSD 132 (323)
Q Consensus 79 ~---------------------~~~~~~v~k~~~iPiE~VvR~y~~GS~~~~~~~~~k~~~~~~~g-----~~lp~gl~~ 132 (323)
. ..+++.++++..+|.+.++|+|.+||+++.++..+.......|. +..++++..
T Consensus 83 ~~~t~~~~~p~~~~~~~~v~~~~~ts~f~k~~~~vp~~~~~~~~~~~S~~k~~a~~~n~~g~e~~~~~~~~li~r~~~~~ 162 (373)
T KOG2835 83 CGETAFEARPCPMTPIEWVTRRCATSSFEKKNPGVPEGYRFRGYKTESTFKDDANMDNVWGDEQIIDCAGLLIGRDEVKI 162 (373)
T ss_pred CCHHHHHCCCCCCCCCEEEEEECCHHHHHHHCCCCCCCEEECCCCCCCCCCCHHHCCCCCCHHHHHHHHHHHCCHHHCCC
T ss_conf 44134422788778730478622236688758667654153476565200221223763330134444433301011441
Q ss_pred CCCCCCCCEEEEEECCCCCCCCCCCCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEEEEECCCC
Q ss_conf 35688740223210333345777555545666530499899989999999999999999886797887423244550886
Q gi|254780493|r 133 NQKLPYPVITPTTKSSESASGCDQPISPNEIIHRGILTRNQWETISSYALSLFERGCKLALENGLILVDSKYEFGIDKKQ 212 (323)
Q Consensus 133 ~~~l~~Pi~tpstK~~~~~~~~D~~i~~~~~~~~~~~~~~~~~~i~~~sl~i~~~~~~~~~~~GliLvD~K~EFG~~~~g 212 (323)
+++++.++| |++|+... .||.+|++..++. .++..+...........+........+.|.+.+|+|+|||+++..
T Consensus 163 ~~~~~~~if-es~k~~~~--~h~~~I~d~~ie~--gv~~~~~~~~~a~~v~~~~~~r~~~~~d~~im~D~~~~~d~~~vt 237 (373)
T KOG2835 163 MQKLPLYIF-ESLKAAWA--GHNCAISDMKIEF--GVDVTLGEIVLASDVIDNDSWRMWPDGDGRIMKDKKVYFDLDEVT 237 (373)
T ss_pred CCCCCCCHH-HHHHHHHC--CCCCCCCCCHHHH--CCCHHHHHHHHHHCCCCHHHEEEEECCCCCEEEEEEEEECCCCCC
T ss_conf 000440001-02345424--7765356423444--033436555553103531234770067766443006784565777
Q ss_pred C--EEEECCCCCCCCCH-----------HHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCC--------------
Q ss_conf 2--57620004810000-----------00000001233125444432378887655311223679--------------
Q gi|254780493|r 213 N--IILADEIHTPDSSR-----------YWEVETYEKSFREGITPIGLDKDFIRNWILTRCNPYRD-------------- 265 (323)
Q Consensus 213 ~--iiL~DEv~TPDssR-----------~W~~~~ye~~~~~g~~~~s~DKq~~R~wl~~~~~~~~~-------------- 265 (323)
. ++|+|+.+|||++| +|-+..|+. |..+.++|+||.|+|+..++-...+
T Consensus 238 ~e~~ilv~~~~t~~msr~a~~a~~~~~~~~iaga~~~----~~~p~~v~a~f~~~gvp~~~~~~dg~~~~l~~V~~~~~~ 313 (373)
T KOG2835 238 NEGLILVDENTTPVMSRYATSAKSRGVVLWIAGAYKA----GHEPLMVDAEFERPGVPVVFVAVDGRDNLLSIVQMPNGV 313 (373)
T ss_pred CCCEEEEEECCCHHHHHHHHHCCCCCEEEEEECCCCC----CCCHHHHHHHCCCCCCCEEEEECCCCCCCCCCEECCCCC
T ss_conf 5115888403770466665402566618999516777----777256776463668523321115533444503336776
Q ss_pred ----CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf ----99998989999999999999998608866478867899999999999999985
Q gi|254780493|r 266 ----NIPDIPENIILRTSQTYIAAYEKITGLKFIADNSELPPLERIRNNLRKYTHRH 318 (323)
Q Consensus 266 ----~~P~LP~~vv~~~~~~Y~~~~e~lTG~~f~~~~~~~~~~erI~~~l~~~~~~~ 318 (323)
.++..|++.+..++.+|...++.|||+.+..-+.+.+.+.++-+.|+.-+++-
T Consensus 314 ~~~~v~v~~p~~aa~~aar~l~~~~~~i~gk~~~~~l~~~~~~~~~~~Kle~~~~~~ 370 (373)
T KOG2835 314 PVATVAVNNPENAALLAARILGLSNEMITGKMRSYQLNQQIIILNKDRKLETVGWEP 370 (373)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCHHHHHHHHHHHHCCCCC
T ss_conf 445546689789999999999753167688788741122278887765676506763
No 15
>KOG2835 consensus
Probab=98.96 E-value=6.4e-11 Score=89.53 Aligned_cols=142 Identities=23% Similarity=0.261 Sum_probs=109.0
Q ss_pred CEEEECCCCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCHHHH
Q ss_conf 00000254650578852122443220012210247651344663212223568874022321033334577755554566
Q gi|254780493|r 84 LVGQQLQMFPIELIVRGYLAGNTKTSLLTFYKNGKRKIYEYLLPDNMSDNQKLPYPVITPTTKSSESASGCDQPISPNEI 163 (323)
Q Consensus 84 ~~v~k~~~iPiE~VvR~y~~GS~~~~~~~~~k~~~~~~~g~~lp~gl~~~~~l~~Pi~tpstK~~~~~~~~D~~i~~~~~ 163 (323)
..+++|.|+|.|.++|.-++||+.+.+. .++ ++-++..+...-+-|.+ +.+|+....+++
T Consensus 88 ~~~~p~~~~~~~~v~~~~~ts~f~k~~~--------~vp---------~~~~~~~~~~~S~~k~~---a~~~n~~g~e~~ 147 (373)
T KOG2835 88 FEARPCPMTPIEWVTRRCATSSFEKKNP--------GVP---------EGYRFRGYKTESTFKDD---ANMDNVWGDEQI 147 (373)
T ss_pred HHCCCCCCCCCEEEEEECCHHHHHHHCC--------CCC---------CCEEECCCCCCCCCCCH---HHCCCCCCHHHH
T ss_conf 4227887787304786222366887586--------676---------54153476565200221---223763330134
Q ss_pred HHH--HCCCHHHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEEEEECC-CCCEEEE-CCCCCCCCCHHHCCCHHHHHHH
Q ss_conf 653--04998999899999999999999998867978874232445508-8625762-0004810000000000012331
Q gi|254780493|r 164 IHR--GILTRNQWETISSYALSLFERGCKLALENGLILVDSKYEFGIDK-KQNIILA-DEIHTPDSSRYWEVETYEKSFR 239 (323)
Q Consensus 164 ~~~--~~~~~~~~~~i~~~sl~i~~~~~~~~~~~GliLvD~K~EFG~~~-~g~iiL~-DEv~TPDssR~W~~~~ye~~~~ 239 (323)
... -+.+++++..++...+-+|......+..+...++|.|.|||.+. .++++++ |++ ..|++|.|+.
T Consensus 148 ~~~~~~li~r~~~~~~~~~~~~ifes~k~~~~~h~~~I~d~~ie~gv~~~~~~~~~a~~v~-~~~~~r~~~~-------- 218 (373)
T KOG2835 148 IDCAGLLIGRDEVKIMQKLPLYIFESLKAAWAGHNCAISDMKIEFGVDVTLGEIVLASDVI-DNDSWRMWPD-------- 218 (373)
T ss_pred HHHHHHHCCHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHCCCHHHHHHHHHHCCC-CHHHEEEEEC--------
T ss_conf 4444333010114410004400010234542477653564234440334365555531035-3123477006--------
Q ss_pred CCCCCCCCCHHHHHHH
Q ss_conf 2544443237888765
Q gi|254780493|r 240 EGITPIGLDKDFIRNW 255 (323)
Q Consensus 240 ~g~~~~s~DKq~~R~w 255 (323)
+..+.+.||++.++-
T Consensus 219 -~d~~im~D~~~~~d~ 233 (373)
T KOG2835 219 -GDGRIMKDKKVYFDL 233 (373)
T ss_pred -CCCCEEEEEEEEECC
T ss_conf -776644300678456
No 16
>TIGR01648 hnRNP-R-Q hnRNP-R, Q splicing factor family; InterPro: IPR006535 Sequences in this subfamily include the human heterogeneous nuclear ribonucleoproteins (hnRNP) R , Q and APOBEC-1 complementation factor (aka APOBEC-1 stimulating protein) . These proteins contain three RNA recognition domains and a somewhat variable C-terminal domain. .
Probab=98.22 E-value=1.3e-08 Score=74.72 Aligned_cols=142 Identities=18% Similarity=0.247 Sum_probs=114.9
Q ss_pred HHHHHHHHHHHHHHHHHHCCCEEEEEEEEEEECCCCCEEEECCCCCCCCCHHHCCCHHHHHHHCCCCCCCCCHHHHHHHH
Q ss_conf 99999999999999988679788742324455088625762000481000000000001233125444432378887655
Q gi|254780493|r 177 ISSYALSLFERGCKLALENGLILVDSKYEFGIDKKQNIILADEIHTPDSSRYWEVETYEKSFREGITPIGLDKDFIRNWI 256 (323)
Q Consensus 177 i~~~sl~i~~~~~~~~~~~GliLvD~K~EFG~~~~g~iiL~DEv~TPDssR~W~~~~ye~~~~~g~~~~s~DKq~~R~wl 256 (323)
+.--..+||--+.-...+++-||-.++. -..+--++||-..--+---+|-+..-+||++.+..+....|=.-.++-|-
T Consensus 139 ~SVdNcRLFvGgIPK~KkreeILeE~~K--VTEGvvdVIvY~saaDK~KNRGFaFvEYEsHraAA~ARRkLmpGri~lWG 216 (611)
T TIGR01648 139 ISVDNCRLFVGGIPKTKKREEILEEISK--VTEGVVDVIVYASAADKKKNRGFAFVEYESHRAAAMARRKLMPGRIQLWG 216 (611)
T ss_pred EEEECCEEEECCCCCCCCHHHHHHHHHH--HCCCEEEEEEECCCCCCCCCCCEEEEEEHHHHHHHHHHHHCCCCCEEEEC
T ss_conf 7870571144674888851226767533--01332566870783656667631475102058999998630897188703
Q ss_pred HHCCCCCCCCCCCCCHHHHHHHHHHHH-----HHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCC
Q ss_conf 311223679999989899999999999-----9999860886647886789999999999999998520379
Q gi|254780493|r 257 LTRCNPYRDNIPDIPENIILRTSQTYI-----AAYEKITGLKFIADNSELPPLERIRNNLRKYTHRHLSSRN 323 (323)
Q Consensus 257 ~~~~~~~~~~~P~LP~~vv~~~~~~Y~-----~~~e~lTG~~f~~~~~~~~~~erI~~~l~~~~~~~~~~~~ 323 (323)
+....+|.+|.-++.+||+.+|.-+|+ +..|-+.-++|.--+|. -+|||++ |++|.++||+||.
T Consensus 217 h~iaVdWAeP~~evDedvM~~VKiLyVRNL~~~ttEE~ieKsF~~f~PG--~vERVKK-irDYAFVHF~~Re 285 (611)
T TIGR01648 217 HVIAVDWAEPEVEVDEDVMAKVKILYVRNLMLETTEEIIEKSFSEFKPG--AVERVKK-IRDYAFVHFEDRE 285 (611)
T ss_pred CEEEEECCCCCCCCCCCCCCCCEEEEEECCHHHHHHHHHHHHCCCCCCC--CEEEEEE-ECCEEEEEECCHH
T ss_conf 5178612588315872201610278883321342143332012567997--2454311-0121364016867
No 17
>KOG0117 consensus
Probab=94.18 E-value=0.00022 Score=47.87 Aligned_cols=106 Identities=16% Similarity=0.234 Sum_probs=79.0
Q ss_pred CEEEECCCCCCCCCHHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH-----HHHH
Q ss_conf 25762000481000000000001233125444432378887655311223679999989899999999999-----9999
Q gi|254780493|r 213 NIILADEIHTPDSSRYWEVETYEKSFREGITPIGLDKDFIRNWILTRCNPYRDNIPDIPENIILRTSQTYI-----AAYE 287 (323)
Q Consensus 213 ~iiL~DEv~TPDssR~W~~~~ye~~~~~g~~~~s~DKq~~R~wl~~~~~~~~~~~P~LP~~vv~~~~~~Y~-----~~~e 287 (323)
++||.-+--.---+|-+..-.|+.+.+.......+-..-++-|-+..-.+|.+|.-+..+|++.+|..+|+ ...|
T Consensus 194 dVivy~~p~dk~KNRGFaFveYe~H~~Aa~aRrKl~~g~~klwgn~~tVdWAep~~e~ded~ms~VKvLYVRNL~~~tTe 273 (506)
T KOG0117 194 DVIVYPSPDDKTKNRGFAFVEYESHRAAAMARRKLMPGKIKLWGNAITVDWAEPEEEPDEDTMSKVKVLYVRNLMESTTE 273 (506)
T ss_pred EEEEECCCCCCCCCCCEEEEEEECCHHHHHHHHHCCCCCEEECCCCCEEECCCCCCCCCHHHHHHEEEEEEECCCHHHHH
T ss_conf 89972586644445633899860415589998642688445227753154358556888503655403656324125559
Q ss_pred HHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCC
Q ss_conf 860886647886789999999999999998520379
Q gi|254780493|r 288 KITGLKFIADNSELPPLERIRNNLRKYTHRHLSSRN 323 (323)
Q Consensus 288 ~lTG~~f~~~~~~~~~~erI~~~l~~~~~~~~~~~~ 323 (323)
-..-+.|.-- . -++||.+ +++|.++||++|.
T Consensus 274 E~lk~~F~~~-G---~veRVkk-~rDYaFVHf~eR~ 304 (506)
T KOG0117 274 ETLKKLFNEF-G---KVERVKK-PRDYAFVHFAERE 304 (506)
T ss_pred HHHHHHHHHC-C---CEEEEEC-CCCEEEEEECCHH
T ss_conf 9999999750-6---4688602-3421478642237
No 18
>pfam01259 SAICAR_synt SAICAR synthetase. Also known as Phosphoribosylaminoimidazole-succinocarboxamide synthase.
Probab=89.15 E-value=0.79 Score=25.20 Aligned_cols=102 Identities=17% Similarity=0.105 Sum_probs=60.5
Q ss_pred CCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEEEE
Q ss_conf 21222356887402232103333457775555456665304998999899999999999999998867978874232445
Q gi|254780493|r 128 DNMSDNQKLPYPVITPTTKSSESASGCDQPISPNEIIHRGILTRNQWETISSYALSLFERGCKLALENGLILVDSKYEFG 207 (323)
Q Consensus 128 ~gl~~~~~l~~Pi~tpstK~~~~~~~~D~~i~~~~~~~~~~~~~~~~~~i~~~sl~i~~~~~~~~~~~GliLvD~K~EFG 207 (323)
.|..+|.+||+|+++++.|.+. .+||.++.++...+++...... .+.+.++.+.+.+.+..-+|.+.
T Consensus 104 ~g~~~G~~l~~~l~e~~~k~d~---~~dP~~k~e~d~~l~~~~~~~~-----~~~ee~~~i~~~al~i~~~l~~~----- 170 (243)
T pfam01259 104 TGVVEGIKLPPGLVESFYKPDA---IFDPSTKAEHDENISFAQAELL-----VGKEEADRMKEKTLALYEKLKKY----- 170 (243)
T ss_pred CCCCCCCCCCCCHHHHHCCCCC---CCCCCCCHHHHHHCCHHHHHHH-----CCHHHHHHHHHHHHHHHHHHHHH-----
T ss_conf 7973687489544665426522---3688468999985898575421-----59999999999999999999999-----
Q ss_pred ECCCCCEEEEC---CCCCCCCC-HHHCCCHHHHHHHCCCCCCCCCHHHHHHHHH
Q ss_conf 50886257620---00481000-0000000012331254444323788876553
Q gi|254780493|r 208 IDKKQNIILAD---EIHTPDSS-RYWEVETYEKSFREGITPIGLDKDFIRNWIL 257 (323)
Q Consensus 208 ~~~~g~iiL~D---Ev~TPDss-R~W~~~~ye~~~~~g~~~~s~DKq~~R~wl~ 257 (323)
-....++|+| |+| -|+. ++--+| .++++--|-|-.
T Consensus 171 -~~~~Gl~LvD~K~EFG-~~~~g~ivL~D-------------EI~PDs~R~Wd~ 209 (243)
T pfam01259 171 -AADKGIILVDTKFEFG-LDKDGEILLAD-------------EISPDSSRLWDA 209 (243)
T ss_pred -HHHCCCEEEEEEEEEE-ECCCCCEEEEE-------------EECCCCCCCEEC
T ss_conf -9978988999778986-76999599998-------------667974433168
No 19
>COG3473 Maleate cis-trans isomerase [Secondary metabolites biosynthesis, transport, and catabolism]
Probab=58.03 E-value=3.1 Score=21.45 Aligned_cols=88 Identities=19% Similarity=0.274 Sum_probs=55.3
Q ss_pred CCCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 54650578852122443220012210247651344663212223568874022321033334577755554566653049
Q gi|254780493|r 90 QMFPIELIVRGYLAGNTKTSLLTFYKNGKRKIYEYLLPDNMSDNQKLPYPVITPTTKSSESASGCDQPISPNEIIHRGIL 169 (323)
Q Consensus 90 ~~iPiE~VvR~y~~GS~~~~~~~~~k~~~~~~~g~~lp~gl~~~~~l~~Pi~tpstK~~~~~~~~D~~i~~~~~~~~~~~ 169 (323)
--..+++|+=+-.+||+...- .| .-.+..-+.+.. +-|.+|+++-.-+ +++.+
T Consensus 64 ada~vdvI~Y~CtsgS~i~G~-~~---------d~ei~~~ie~~~--~v~vvTts~Avv~---------------aL~al 116 (238)
T COG3473 64 ADAGVDVIVYGCTSGSLIGGP-GY---------DKEIAQRIEEAK--GVPVVTTSTAVVE---------------ALNAL 116 (238)
T ss_pred CCCCCCEEEEECCCEEEECCC-CH---------HHHHHHHHHHCC--CCCEEECHHHHHH---------------HHHHH
T ss_conf 756667899962620164277-45---------599999998626--9855614089999---------------99861
Q ss_pred CHHHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEE
Q ss_conf 98999899999999999999998867978874232
Q gi|254780493|r 170 TRNQWETISSYALSLFERGCKLALENGLILVDSKY 204 (323)
Q Consensus 170 ~~~~~~~i~~~sl~i~~~~~~~~~~~GliLvD~K~ 204 (323)
+.....-+.-+...+++...++++.+|+..||+|=
T Consensus 117 ~a~ri~vlTPY~~evn~~e~ef~~~~Gfeiv~~~~ 151 (238)
T COG3473 117 GAQRISVLTPYIDEVNQREIEFLEANGFEIVDFKG 151 (238)
T ss_pred CCCEEEEECCCHHHHHHHHHHHHHHCCEEEEEEEC
T ss_conf 75158985253054415899999848927997541
No 20
>TIGR01828 pyru_phos_dikin pyruvate, phosphate dikinase; InterPro: IPR010121 Pyruvate phosphate dikinase (PPDK, or pyruvate orthophosphate dikinase) is found in plants, bacteria and archaea. The amino acid sequence identity between bacterial and plant enzymes is high, and they are similar in sequence to other PEP-utilizing enzymes. PPDK catalyses the reversible conversion of ATP and pyruvate to AMP and PEP (phosphoenolpyruvate). In bacteria such as Clostridium symbiosum, PPDK uses Mg2+ and NH4+ ions as cofactors . The enzyme has three domains: the N- and C-terminal domains each have an active site centre that catalyses a different step in the reaction, and the middle domain has a carrier histidine residue that moves between the two active centres. In plants, PPDK is localised predominantly in chloroplast stroma where it catalyses the rate-limiting step in the C4 photosynthetic pathway, namely the synthesis of PEP, which acts as the primary CO2 acceptor in C4 photosynthesis . PPDK activity in C4 plants is strictly regulated by light, its activity decreasing in darkness. This response is regulated by phosphorylation and dephosphorylation of the enzyme using ADP; such regulation is not seen in the bacterial form of the enzyme. PPDK is also found in C3 plants, but it is not known to have a photosynthetic role .; GO: 0050242 pyruvate phosphate dikinase activity.
Probab=52.71 E-value=17 Score=16.64 Aligned_cols=144 Identities=17% Similarity=0.238 Sum_probs=84.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHHH-HHCCCEEE--------------EEEEEEEECCCCCEEEECCCCCCCCCHHHCCCH
Q ss_conf 998999899999999999999998-86797887--------------423244550886257620004810000000000
Q gi|254780493|r 169 LTRNQWETISSYALSLFERGCKLA-LENGLILV--------------DSKYEFGIDKKQNIILADEIHTPDSSRYWEVET 233 (323)
Q Consensus 169 ~~~~~~~~i~~~sl~i~~~~~~~~-~~~GliLv--------------D~K~EFG~~~~g~iiL~DEv~TPDssR~W~~~~ 233 (323)
..++..+++.+.--.|=+..-+.| ..-+-.|| ||=+=-|+|..---=||.- | +.-|| .-|+
T Consensus 63 ~P~gl~eE~~~~l~~lE~~~GK~FG~~~nPLLVSVRSGA~~SMPGMMDTvLNLGLND~~V~GLA~~--t-gn~RF-AyDS 138 (920)
T TIGR01828 63 FPKGLQEEVKEALKKLEEKTGKKFGDAENPLLVSVRSGAAVSMPGMMDTVLNLGLNDETVKGLAKL--T-GNARF-AYDS 138 (920)
T ss_pred CCHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCCCCCCCHHHHCCCCCHHHHHHHHHC--C-CCCCH-HHHH
T ss_conf 886479999999999998716305769988312122678888978526650245526899998614--6-88422-5687
Q ss_pred HHHHHHC--CCCCCCCCHHHHHHHHHHCCC-CCCCCCCCCCHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHH
Q ss_conf 0123312--544443237888765531122-36799999898999999999999999860-8866478867899999999
Q gi|254780493|r 234 YEKSFRE--GITPIGLDKDFIRNWILTRCN-PYRDNIPDIPENIILRTSQTYIAAYEKIT-GLKFIADNSELPPLERIRN 309 (323)
Q Consensus 234 ye~~~~~--g~~~~s~DKq~~R~wl~~~~~-~~~~~~P~LP~~vv~~~~~~Y~~~~e~lT-G~~f~~~~~~~~~~erI~~ 309 (323)
|. ||-+ |.--=..+++-|++-+..... .+..--++|..+=+.++.+.|+.+|+.-| |++|-- ||.|.+..
T Consensus 139 YR-RFiqMFG~vVl~ip~~~Fe~~le~~K~e~g~~~DT~Lta~Dl~~li~~yk~~~~~~~nG~~FPq-----DP~eQL~~ 212 (920)
T TIGR01828 139 YR-RFIQMFGDVVLGIPHELFEQALENLKKEKGVKLDTDLTADDLKELIEKYKKIYREATNGKDFPQ-----DPKEQLEL 212 (920)
T ss_pred HH-HHHHHHHHHHCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCC-----CHHHHHHH
T ss_conf 78-8988420142179836889999999876288558513678899999999999999866898773-----31899999
Q ss_pred HHHHHHHHHHCCC
Q ss_conf 9999999852037
Q gi|254780493|r 310 NLRKYTHRHLSSR 322 (323)
Q Consensus 310 ~l~~~~~~~~~~~ 322 (323)
++..=+.+-=+.|
T Consensus 213 Ai~AVF~SW~n~R 225 (920)
T TIGR01828 213 AIKAVFDSWNNPR 225 (920)
T ss_pred HHHHHHCCCCCCH
T ss_conf 9999831568730
No 21
>KOG0667 consensus
Probab=51.39 E-value=18 Score=16.57 Aligned_cols=112 Identities=25% Similarity=0.317 Sum_probs=55.7
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCEEEEEEEEEEECCCCCEEEECCCCCCCCCHH--HCCCHHHHHHHCCCCCCCCCHHHHH
Q ss_conf 99999999999999998867978874232445508862576200048100000--0000001233125444432378887
Q gi|254780493|r 176 TISSYALSLFERGCKLALENGLILVDSKYEFGIDKKQNIILADEIHTPDSSRY--WEVETYEKSFREGITPIGLDKDFIR 253 (323)
Q Consensus 176 ~i~~~sl~i~~~~~~~~~~~GliLvD~K~EFG~~~~g~iiL~DEv~TPDssR~--W~~~~ye~~~~~g~~~~s~DKq~~R 253 (323)
.++..+..+-..+. ++.+.|||+.|-|=| +|+|.|- +.||+ -|. |.+ .+..|.+=
T Consensus 290 ~ir~~~~Qil~~L~-~L~~l~IIHcDLKPE-------NILL~~~----~r~~vKVIDF---------GSS--c~~~q~vy 346 (586)
T KOG0667 290 LVRKFAQQILTALL-FLHELGIIHCDLKPE-------NILLKDP----KRSRIKVIDF---------GSS--CFESQRVY 346 (586)
T ss_pred HHHHHHHHHHHHHH-HHHHCCEEECCCCHH-------HEEECCC----CCCCEEEEEC---------CCC--CCCCCCCE
T ss_conf 99999999999999-998679624258757-------6564167----7676169844---------531--11477522
Q ss_pred HHHHHCCCCCCCC--CCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 6553112236799--9998989999999999999998608866478867899999999999
Q gi|254780493|r 254 NWILTRCNPYRDN--IPDIPENIILRTSQTYIAAYEKITGLKFIADNSELPPLERIRNNLR 312 (323)
Q Consensus 254 ~wl~~~~~~~~~~--~P~LP~~vv~~~~~~Y~~~~e~lTG~~f~~~~~~~~~~erI~~~l~ 312 (323)
.|+-.+ =++.| +--+|=+.--+....=.-++|..||.++++=....|-.-||.+.+-
T Consensus 347 tYiQSR--fYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG 405 (586)
T KOG0667 347 TYIQSR--FYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLG 405 (586)
T ss_pred EEEECC--CCCCCHHHCCCCCCCCCCEEEHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHC
T ss_conf 433120--24664531068768721233043467766328535789888999999998707
No 22
>TIGR00513 accA acetyl-CoA carboxylase, carboxyl transferase, alpha subunit; InterPro: IPR001095 This entry contains the alpha subunit the acetyl coenzyme A carboxylase complex (). It catalyzes the first step in the synthesis of long-chain fatty acids which involves the carboxylation of acetyl-CoA to malonyl-CoA. The acetyl-CoA carboxylase complex () is a heterohexamer of biotin carboxyl carrier protein, biotin carboxylase and two non-identical carboxyl transferase subunits (alpha and beta) in a 2:2 association . The reaction involves two steps: Biotin carrier protein + ATP + HCO_3^- -> Carboxybiotin carrier protein + ADP + P_i Carboxybiotin carrier protein + Acetyl-CoA -> Malonyl-CoA + Biotin carrier protein ; GO: 0003989 acetyl-CoA carboxylase activity, 0006633 fatty acid biosynthetic process, 0009317 acetyl-CoA carboxylase complex.
Probab=50.35 E-value=11 Score=17.81 Aligned_cols=52 Identities=15% Similarity=0.094 Sum_probs=38.8
Q ss_pred CEEEECCCCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCC-------CCCCCCCEEEE
Q ss_conf 00000254650578852122443220012210247651344663212223-------56887402232
Q gi|254780493|r 84 LVGQQLQMFPIELIVRGYLAGNTKTSLLTFYKNGKRKIYEYLLPDNMSDN-------QKLPYPVITPT 144 (323)
Q Consensus 84 ~~v~k~~~iPiE~VvR~y~~GS~~~~~~~~~k~~~~~~~g~~lp~gl~~~-------~~l~~Pi~tps 144 (323)
.=|-|+.-.||=||--.- ++..|.....-+|.|-|+|.+++ +||.-||+|+=
T Consensus 108 GG~Arldg~PV~viGhqK---------Gr~tKek~~RNFGMP~P~GYRKALrLm~~AerF~~PIi~fi 166 (329)
T TIGR00513 108 GGVARLDGRPVVVIGHQK---------GRDTKEKLLRNFGMPAPEGYRKALRLMKMAERFNLPIITFI 166 (329)
T ss_pred EEEEEECCCCEEEEECCC---------CCCCHHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCEEEEE
T ss_conf 321133781248862135---------75403421125798879604799999987776179858865
No 23
>cd05594 STKc_PKB_alpha STKc_PKB_alpha: Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, r
Probab=49.63 E-value=19 Score=16.34 Aligned_cols=38 Identities=24% Similarity=0.213 Sum_probs=25.5
Q ss_pred HHHHHHHHHHHHHHCCCEEEEEEEEEEE-CCCCCEEEEC
Q ss_conf 9999999999988679788742324455-0886257620
Q gi|254780493|r 181 ALSLFERGCKLALENGLILVDSKYEFGI-DKKQNIILAD 218 (323)
Q Consensus 181 sl~i~~~~~~~~~~~GliLvD~K~EFG~-~~~g~iiL~D 218 (323)
+..+...+.-+-.++|+++=|.|-|==+ +.+|.+-|+|
T Consensus 101 ~~qi~~aL~yLHs~~~IiHRDLKPeNILl~~~g~iKL~D 139 (324)
T cd05594 101 GAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITD 139 (324)
T ss_pred HHHHHHHHHHHHHHCCEECCCCCCCCCCCCCCCCEEECC
T ss_conf 999999999999837971143456555647888773122
No 24
>cd05625 STKc_LATS1 STKc_LATS1: Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It
Probab=49.44 E-value=20 Score=16.32 Aligned_cols=33 Identities=24% Similarity=0.257 Sum_probs=25.6
Q ss_pred HHHHHHHCCCEEEEEEEEEEE-CCCCCEEEECCCC
Q ss_conf 999988679788742324455-0886257620004
Q gi|254780493|r 188 GCKLALENGLILVDSKYEFGI-DKKQNIILADEIH 221 (323)
Q Consensus 188 ~~~~~~~~GliLvD~K~EFG~-~~~g~iiL~DEv~ 221 (323)
+-+++-++||++=|.|-|==+ +.+|.+-|+| +|
T Consensus 113 aL~~lH~~gIiHRDLKPeNILld~~g~iKL~D-FG 146 (382)
T cd05625 113 AVESVHKMGFIHRDIKPDNILIDRDGHIKLTD-FG 146 (382)
T ss_pred HHHHHHHCCCCCCCCCCCEEEECCCCCEEEEE-CC
T ss_conf 99999855540155766637888999889940-68
No 25
>KOG1228 consensus
Probab=48.86 E-value=20 Score=16.26 Aligned_cols=67 Identities=18% Similarity=0.167 Sum_probs=46.2
Q ss_pred ECCEEEECCCCCCCCCHHH-------------HHHHHHHHHHHHHHHHCCCCEECCCCCCCCEEEECCCCCCEEEEECCC
Q ss_conf 1881255576577787889-------------999999999998541023312135776300000025465057885212
Q gi|254780493|r 36 TDRLSAFDQNIACIPYKGE-------------VLNQITQYWFHHTSDICSNHTLDYPDPNVLVGQQLQMFPIELIVRGYL 102 (323)
Q Consensus 36 tDriSAfD~~~~~Ip~KG~-------------~l~~iS~~~F~~l~~~i~tH~i~~~~~~~~~v~k~~~iPiE~VvR~y~ 102 (323)
+-|||+|+...+++.+||+ .--.+++.-|..+.+.|| -.+...-++.+.+++=|-|-||-..
T Consensus 55 SGRIsvl~qg~N~~~~k~qgg~WLyVTHd~~a~ddl~~~lef~~~sgkip-----pv~g~rei~ykfEP~IlhVqcrdlq 129 (256)
T KOG1228 55 SGRISVLDQGINGFEVKGQGGCWLYVTHDLCAKDDLIVALEFAELSGKIP-----PVNGIREITYKFEPFILHVQCRDLQ 129 (256)
T ss_pred CCEEEEEEECCCCCCCCCCCCEEEEEECCCCHHCCCCHHHHHHHHHCCCC-----CCCCCHHHEEECCCEEEEEEHHHHH
T ss_conf 63379985046764435777459999556001001004432277608889-----8787442123226538998600035
Q ss_pred CCCCC
Q ss_conf 24432
Q gi|254780493|r 103 AGNTK 107 (323)
Q Consensus 103 ~GS~~ 107 (323)
..+..
T Consensus 130 ~Aq~L 134 (256)
T KOG1228 130 DAQIL 134 (256)
T ss_pred HHHHH
T ss_conf 68999
No 26
>TIGR01825 gly_Cac_T_rel pyridoxal phosphate-dependent acyltransferase, putative; InterPro: IPR010962 Pyridoxal phosphate is the active form of vitamin B6 (pyridoxine or pyridoxal). PLP is a versatile catalyst, acting as a coenzyme in a multitude of reactions, including decarboxylation, deamination and transamination , , . PLP-dependent enzymes are primarily involved in the biosynthesis of amino acids and amino acid-derived metabolites, but they are also found in the biosynthetic pathways of amino sugars and in the synthesis or catabolism of neurotransmitters; pyridoxal phosphate can also inhibit DNA polymerases and several steroid receptors . Inadequate levels of pyridoxal phosphate in the brain can cause neurological dysfunction, particularly epilepsy . PLP enzymes exist in their resting state as a Schiff base, the aldehyde group of PLP forming a linkage with the epsilon-amino group of an active site lysine residue on the enzyme. The alpha-amino group of the substrate displaces the lysine epsilon-amino group, in the process forming a new aldimine with the substrate. This aldimine is the common central intermediate for all PLP-catalyzed reactions, enzymatic and non-enzymatic . This entry contains a number of enzyme families: Serine palmitoyltransferase Glycine C-acetyltransferase (2-amino-3-ketobutyrate coenzyme A ligase) 5-aminolevulinic acid synthase 8-amino-7-oxononanoate synthase All transfer the R-group (acetyl, succinyl, or 6-carboxyhexanoyl) from coenzyme A to an amino acid (Gly, Gly, Ala, respectively), with release of CO2 for the latter two reactions.; GO: 0016740 transferase activity, 0030170 pyridoxal phosphate binding.
Probab=44.56 E-value=23 Score=15.84 Aligned_cols=199 Identities=17% Similarity=0.161 Sum_probs=98.8
Q ss_pred ECCEEEEEECC-------------CC---CEEEEEECCEEEECCCCCCCCCHHHHHHHHHHHHH-------HHHH---HH
Q ss_conf 04402658759-------------99---48999818812555765777878899999999999-------9854---10
Q gi|254780493|r 17 SGKVRENYFLS-------------DG---TRITIATDRLSAFDQNIACIPYKGEVLNQITQYWF-------HHTS---DI 70 (323)
Q Consensus 17 ~GKvk~vY~~~-------------d~---~ll~v~tDriSAfD~~~~~Ip~KG~~l~~iS~~~F-------~~l~---~~ 70 (323)
++=.|.+|..- +. .+-|+-||=+=.-|+-+...|.==++.-+--++-+ --+- ..
T Consensus 139 tkA~k~~y~H~dm~DL~~~l~e~~~~Gqy~~~l~vTDGVFSMDGdvApLp~iVE~Ae~Yda~~yVDDAHGsGVlGe~GrG 218 (392)
T TIGR01825 139 TKAKKKIYKHVDMDDLERVLRENVEEGQYKKKLIVTDGVFSMDGDVAPLPEIVELAEKYDALVYVDDAHGSGVLGEKGRG 218 (392)
T ss_pred CCCCEEEEECCCHHHHHHHHHHCCCCCCCCCEEEEECCEEECCCCCCCCCHHHHHHHHCCCEEEEECCCCCCCCCCCCCC
T ss_conf 78856898459845899999716033754436899665042567878873233463245957998633466444778871
Q ss_pred CCCCEE-CCCCCCCCEEEECCCCCCEEEEECCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEECCC
Q ss_conf 233121-3577630000002546505788521224432200122102476513446632122235688740223210333
Q gi|254780493|r 71 CSNHTL-DYPDPNVLVGQQLQMFPIELIVRGYLAGNTKTSLLTFYKNGKRKIYEYLLPDNMSDNQKLPYPVITPTTKSSE 149 (323)
Q Consensus 71 i~tH~i-~~~~~~~~~v~k~~~iPiE~VvR~y~~GS~~~~~~~~~k~~~~~~~g~~lp~gl~~~~~l~~Pi~tpstK~~~ 149 (323)
+-+||= ++..-...+.-=-|-| =||=||+||+- ..-+|.+...|+ |-|||
T Consensus 219 tV~HFGL~y~~v~~qvGTLSKA~---GvvGGY~AG~~--~lidyL~~~aRP--------------------FLFSt---- 269 (392)
T TIGR01825 219 TVKHFGLEYDKVDIQVGTLSKAI---GVVGGYVAGSK--ELIDYLKARARP--------------------FLFST---- 269 (392)
T ss_pred EEECCCCCCCCEEEEECCHHHHH---CCCCCCCCCCH--HHHHHHHHCCCC--------------------CCCCC----
T ss_conf 35303754164678855522322---25664234888--999999862898--------------------60125----
Q ss_pred CCCCCCCCCCHHHHHHHH--CCCHHHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEEEEECCCCCEEEECCCCCCCC-C
Q ss_conf 345777555545666530--4998999899999999999999998867978874232445508862576200048100-0
Q gi|254780493|r 150 SASGCDQPISPNEIIHRG--ILTRNQWETISSYALSLFERGCKLALENGLILVDSKYEFGIDKKQNIILADEIHTPDS-S 226 (323)
Q Consensus 150 ~~~~~D~~i~~~~~~~~~--~~~~~~~~~i~~~sl~i~~~~~~~~~~~GliLvD~K~EFG~~~~g~iiL~DEv~TPDs-s 226 (323)
.+-|.++..-+++.. .-+++..+++.+.|.=+-+.+ .+.|+.|-.++- +=-=+|+.||=.+-.- -
T Consensus 270 ---a~~Pa~~~A~~~Av~~l~~~~~l~~kLW~Nt~ylk~~L----~~LGydl~~S~t-----PItPv~~Gde~~A~efS~ 337 (392)
T TIGR01825 270 ---ALPPAVVAALIEAVDVLQESPELMEKLWDNTRYLKAGL----SKLGYDLGESET-----PITPVLIGDEKVAQEFSR 337 (392)
T ss_pred ---CCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHH----HHHCCCCCCCCC-----CCCCEEECCCHHHHHHHH
T ss_conf ---78807899999999987079314777678899999876----761641147668-----612458765156899999
Q ss_pred HHHCC-CHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 00000-000123312544443237888765531
Q gi|254780493|r 227 RYWEV-ETYEKSFREGITPIGLDKDFIRNWILT 258 (323)
Q Consensus 227 R~W~~-~~ye~~~~~g~~~~s~DKq~~R~wl~~ 258 (323)
|+.+. .=|-. ..+-+-...++-.+|+-.++
T Consensus 338 rL~~~yGvFa~--sivFPTVp~g~ARiR~~~tA 368 (392)
T TIGR01825 338 RLLDEYGVFAQ--SIVFPTVPRGTARIRNIPTA 368 (392)
T ss_pred HHHHHCCEEEE--EEECCCCCCCCCCCCCCCCH
T ss_conf 87775290899--84216566988421246561
No 27
>pfam07347 CI-B14_5a NADH:ubiquinone oxidoreductase subunit B14.5a (Complex I-B14.5a). This family contains the eukaryotic NADH:ubiquinone oxidoreductase subunit B14.5a (Complex I-B14.5a) (EC:1.6.5.3). This is approximately 100 residues long, and forms part of a multiprotein complex that resides on the inner mitochondrial membrane. The main function of the complex is the transport of electrons from NADH to ubiquinone, accompanied by translocation of protons from the mitochondrial matrix to the intermembrane space.
Probab=40.87 E-value=7.1 Score=19.12 Aligned_cols=19 Identities=21% Similarity=0.426 Sum_probs=9.7
Q ss_pred CCCCCCCCHHHHHHHHHHH
Q ss_conf 7999998989999999999
Q gi|254780493|r 264 RDNIPDIPENIILRTSQTY 282 (323)
Q Consensus 264 ~~~~P~LP~~vv~~~~~~Y 282 (323)
.+|+|.||+-.-...+.-|
T Consensus 30 TQp~P~lP~Gp~hkls~Ny 48 (97)
T pfam07347 30 TQPPPKLPDGPSHKLSANY 48 (97)
T ss_pred CCCCCCCCCCCCCCCCCCE
T ss_conf 6998989899533114453
No 28
>TIGR00706 SppA_dom signal peptide peptidase SppA, 36K type; InterPro: IPR004635 Proteolytic enzymes that exploit serine in their catalytic activity are ubiquitous, being found in viruses, bacteria and eukaryotes . They include a wide range of peptidase activity, including exopeptidase, endopeptidase, oligopeptidase and omega-peptidase activity. Over 20 families (denoted S1 - S66) of serine protease have been identified, these being grouped into clans on the basis of structural similarity and other functional evidence . Structures are known for members of the clans and the structures indicate that some appear to be totally unrelated, suggesting different evolutionary origins for the serine peptidases . Not withstanding their different evolutionary origins, there are similarities in the reaction mechanisms of several peptidases. Chymotrypsin, subtilisin and carboxypeptidase C have a catalytic triad of serine, aspartate and histidine in common: serine acts as a nucleophile, aspartate as an electrophile, and histidine as a base . The geometric orientations of the catalytic residues are similar between families, despite different protein folds . The linear arrangements of the catalytic residues commonly reflect clan relationships. For example the catalytic triad in the chymotrypsin clan (PA) is ordered HDS, but is ordered DHS in the subtilisin clan (SB) and SDH in the carboxypeptidase clan (SC) , . Peptidases are grouped into clans and families. Clans are groups of families for which there is evidence of common ancestry. Each clan is identified with two letters, the first representing the catalytic type of the families included in the clan (with the letter 'P' being used for a clan containing families of more than one of the catalytic types serine, threonine and cysteine). Some families cannot yet be assigned to clans, and when a formal assignment is required, such a family is described as belonging to clan A-, C-, M-, S-, T- or U-, according to the catalytic type. Some clans are divided into subclans because there is evidence of a very ancient divergence within the clan, for example MA(E), the gluzincins, and MA(M), the metzincins. Families are grouped by their catalytic type, the first character representing the catalytic type: A, aspartic; C, cysteine; G, glutamic acid; M, metallo; S, serine; T, threonine; and U, unknown. The serine, threonine and cysteine peptidases utilise the amino acid as a nucleophile and form an acyl intermediate - these peptidases can also readily act as transferases. In the case of aspartic, glutamic and metallopeptidases, the nucleophile is an activated water molecule. This group of serine peptidases belong to MEROPS peptidase family S49 (protease IV family, clan S-). The predicted active site serine for members of this family occurs in a transmembrane domain. This group of sequences represent both long and short forms of the bacterial SppA and homologs found in the archaea and plants. Signal peptides of secretory proteins seem to serve at least two important biological functions. First, they are required for protein targeting to and translocation across membranes, such as the eubacterial plasma membrane and the endoplasmic reticular membrane of eukaryotes. Second, in addition to their role as determinants for protein targeting and translocation, certain signal peptides have a signaling function. During or shortly after pre-protein translocation, the signal peptide is removed by signal peptidases. The integral membrane protein, SppA (protease IV), of Escherichia coli was shown experimentally to degrade signal peptides. The member of this family from Bacillus subtilis has only been shown to be required for efficient processing of pre-proteins under conditions of hyper-secretion . ; GO: 0008233 peptidase activity, 0006508 proteolysis.
Probab=38.83 E-value=28 Score=15.28 Aligned_cols=151 Identities=19% Similarity=0.115 Sum_probs=83.5
Q ss_pred CCCCEECCCCCCCCEE---------EEC---CCCCCEEEEECCCC-CCCCCCHHHHHH-CCCCCCCC-CCCCCCCCCCCC
Q ss_conf 2331213577630000---------002---54650578852122-443220012210-24765134-466321222356
Q gi|254780493|r 71 CSNHTLDYPDPNVLVG---------QQL---QMFPIELIVRGYLA-GNTKTSLLTFYK-NGKRKIYE-YLLPDNMSDNQK 135 (323)
Q Consensus 71 i~tH~i~~~~~~~~~v---------~k~---~~iPiE~VvR~y~~-GS~~~~~~~~~k-~~~~~~~g-~~lp~gl~~~~~ 135 (323)
|+--++..++|--.++ +++ .-.||=+.+++++| |+++=++...+- ....++.| +..-=....-.+
T Consensus 44 ~ka~~l~i~SPGG~V~~S~Eiy~~l~~~~k~~kkPVv~~~g~~aaSGGYYia~aa~~I~A~~~t~tGSIGVIl~~~n~~~ 123 (224)
T TIGR00706 44 IKALVLRIDSPGGTVVASEEIYEKLKKLKKEAKKPVVASMGGVAASGGYYIAMAADEIVANPGTITGSIGVILQGANVEK 123 (224)
T ss_pred EEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCEEEEEECCCCHHHHHHHHHCCCEEEECCCCCEECHHHHHHHHHHHH
T ss_conf 00699986379997522689999998634530885899836832267999981388246347742020375520357999
Q ss_pred CCC--CCEEEEEECCCCCCCCCCCCCHHHHHHHHCCCHHHHHHHHHHHHHHHH-HHHHHHHHCC--C------EEEEEEE
Q ss_conf 887--402232103333457775555456665304998999899999999999-9999988679--7------8874232
Q gi|254780493|r 136 LPY--PVITPTTKSSESASGCDQPISPNEIIHRGILTRNQWETISSYALSLFE-RGCKLALENG--L------ILVDSKY 204 (323)
Q Consensus 136 l~~--Pi~tpstK~~~~~~~~D~~i~~~~~~~~~~~~~~~~~~i~~~sl~i~~-~~~~~~~~~G--l------iLvD~K~ 204 (323)
|-+ -|=.-..|+= .|-...++.+. ++++|=+.|.++--.-|+ ++...++.|+ | .|+|++.
T Consensus 124 L~~k~GI~~~~iK~G----~yKd~~~~~R~-----lt~eE~~~lQ~~v~~~Y~~F~~~V~~~R~nkl~~~~vK~~AdGRv 194 (224)
T TIGR00706 124 LLEKLGIEFEAIKSG----EYKDIGSPTRE-----LTPEERKILQSLVNESYEQFVQVVAKGRNNKLSVEDVKKFADGRV 194 (224)
T ss_pred HHHHCCCEEEEEECC----CCCCCCCCHHH-----HHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCHHHHHHHHCCCE
T ss_conf 998649156566516----65678987577-----629999999998888875789999984167789788765206860
Q ss_pred EEEECCCCCEEEECCCCCCCCCHHHCC
Q ss_conf 445508862576200048100000000
Q gi|254780493|r 205 EFGIDKKQNIILADEIHTPDSSRYWEV 231 (323)
Q Consensus 205 EFG~~~~g~iiL~DEv~TPDssR~W~~ 231 (323)
=+|+... ++-|+|+++|-|.-+=|.+
T Consensus 195 f~GrqA~-~l~LVD~lG~~d~A~~~l~ 220 (224)
T TIGR00706 195 FTGRQAL-KLRLVDKLGTLDDALKWLA 220 (224)
T ss_pred ECHHHHH-HCCCEECCCCHHHHHHHHH
T ss_conf 1043343-1146001289899999999
No 29
>cd05595 STKc_PKB_beta STKc_PKB_beta: Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insuli
Probab=38.60 E-value=29 Score=15.26 Aligned_cols=31 Identities=23% Similarity=0.262 Sum_probs=24.0
Q ss_pred HHHHHHHCCCEEEEEEEEEE-ECCCCCEEEEC
Q ss_conf 99998867978874232445-50886257620
Q gi|254780493|r 188 GCKLALENGLILVDSKYEFG-IDKKQNIILAD 218 (323)
Q Consensus 188 ~~~~~~~~GliLvD~K~EFG-~~~~g~iiL~D 218 (323)
+-+++-++|+++=|.|-|=- ++.+|.+-|+|
T Consensus 107 aL~yLH~~~IiHRDLKPeNILl~~~g~iKL~D 138 (323)
T cd05595 107 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITD 138 (323)
T ss_pred HHHHHHHCCEECCCCCHHHCCCCCCCCEEECC
T ss_conf 99999877902365471222303689665223
No 30
>PTZ00284 protein kinase; Provisional
Probab=36.99 E-value=30 Score=15.10 Aligned_cols=36 Identities=19% Similarity=0.165 Sum_probs=20.6
Q ss_pred HHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 999999999998608866478867899999999999
Q gi|254780493|r 277 RTSQTYIAAYEKITGLKFIADNSELPPLERIRNNLR 312 (323)
Q Consensus 277 ~~~~~Y~~~~e~lTG~~f~~~~~~~~~~erI~~~l~ 312 (323)
++...=.-++|.+||...++.....+-...|.+.|.
T Consensus 327 DiWS~gCi~~El~~G~~lF~~~~~~e~L~~m~evLG 362 (467)
T PTZ00284 327 DMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLG 362 (467)
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHC
T ss_conf 888888999999839878899975999999999858
No 31
>cd05570 STKc_PKC STKc_PKC: Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide
Probab=34.14 E-value=34 Score=14.81 Aligned_cols=60 Identities=22% Similarity=0.215 Sum_probs=34.3
Q ss_pred HHHHHHHCCCEEEEEEEEEE-ECCCCCEEEECCCCCCCCCHH--HCCCHHHHHHHCCCCCCCCCHHHHHH
Q ss_conf 99998867978874232445-508862576200048100000--00000012331254444323788876
Q gi|254780493|r 188 GCKLALENGLILVDSKYEFG-IDKKQNIILADEIHTPDSSRY--WEVETYEKSFREGITPIGLDKDFIRN 254 (323)
Q Consensus 188 ~~~~~~~~GliLvD~K~EFG-~~~~g~iiL~DEv~TPDssR~--W~~~~ye~~~~~g~~~~s~DKq~~R~ 254 (323)
+-+++-++|+++=|.|-|== ++.+|.+-|+| +|. ||- ....... ..-..+..+.+|.++.
T Consensus 108 aL~yLH~~~IiHRDLKPeNILl~~~g~iKL~D-FGl---ak~~~~~~~~~~---t~~GTp~YmAPEvl~~ 170 (318)
T cd05570 108 GLQFLHERGIIYRDLKLDNVLLDAEGHIKIAD-FGM---CKEGILGGVTTS---TFCGTPDYIAPEILQG 170 (318)
T ss_pred HHHHHHHCCEEECCCCCCCCEECCCCCEEECC-CCH---HHHHCCCCCCEE---EECCCHHHCCHHHHCC
T ss_conf 99999749778675676542165789788603-403---343057887132---0229846479999838
No 32
>KOG1407 consensus
Probab=32.91 E-value=15 Score=17.03 Aligned_cols=108 Identities=21% Similarity=0.218 Sum_probs=56.9
Q ss_pred CCCCEEEE-EECCEEEECCC----CCCCCCHHHHHHH---HHHHHHHHHHHHCCCCEECCCCCCCCEEEECCCCCCEEEE
Q ss_conf 99948999-81881255576----5777878899999---9999999854102331213577630000002546505788
Q gi|254780493|r 27 SDGTRITI-ATDRLSAFDQN----IACIPYKGEVLNQ---ITQYWFHHTSDICSNHTLDYPDPNVLVGQQLQMFPIELIV 98 (323)
Q Consensus 27 ~d~~ll~v-~tDriSAfD~~----~~~Ip~KG~~l~~---iS~~~F~~l~~~i~tH~i~~~~~~~~~v~k~~~iPiE~Vv 98 (323)
+++..... -.|+|+-+|.. +..-+.|=+++.- ++..+|=++.+...-++++.|+ ---|...+.-|.+|+|
T Consensus 117 ~g~~~~~~~kdD~it~id~r~~~~~~~~~~~~e~ne~~w~~~nd~Fflt~GlG~v~ILsyps--Lkpv~si~AH~snCic 194 (313)
T KOG1407 117 DGEYIAVGNKDDRITFIDARTYKIVNEEQFKFEVNEISWNNSNDLFFLTNGLGCVEILSYPS--LKPVQSIKAHPSNCIC 194 (313)
T ss_pred CCCEEEEECCCCCEEEEEECCCCEEEHHCCCCEEEEEEECCCCCEEEEECCCCEEEEEECCC--CCCCCCCCCCCCCEEE
T ss_conf 99879985476607999700142300101530302456417887799944886589973365--5611201257765399
Q ss_pred -------ECCCCCCC--CCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEEC
Q ss_conf -------52122443--22001221024765134466321222356887402232103
Q gi|254780493|r 99 -------RGYLAGNT--KTSLLTFYKNGKRKIYEYLLPDNMSDNQKLPYPVITPTTKS 147 (323)
Q Consensus 99 -------R~y~~GS~--~~~~~~~~k~~~~~~~g~~lp~gl~~~~~l~~Pi~tpstK~ 147 (323)
|..|+||+ .-|+|+-.+ .+| ++.-.||+-|+=|.|.--
T Consensus 195 I~f~p~GryfA~GsADAlvSLWD~~E----LiC-------~R~isRldwpVRTlSFS~ 241 (313)
T KOG1407 195 IEFDPDGRYFATGSADALVSLWDVDE----LIC-------ERCISRLDWPVRTLSFSH 241 (313)
T ss_pred EEECCCCCEEEECCCCCEEECCCHHH----HHH-------HEEECCCCCCEEEEEECC
T ss_conf 99779986674145430365057267----543-------323101367347887523
No 33
>cd06658 STKc_PAK5 Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is
Probab=32.23 E-value=36 Score=14.61 Aligned_cols=88 Identities=18% Similarity=0.094 Sum_probs=46.0
Q ss_pred HHHHHHHCCCEEEEEEEEEE-ECCCCCEEEECCCCCCCCCHHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCC
Q ss_conf 99998867978874232445-50886257620004810000000000012331254444323788876553112236799
Q gi|254780493|r 188 GCKLALENGLILVDSKYEFG-IDKKQNIILADEIHTPDSSRYWEVETYEKSFREGITPIGLDKDFIRNWILTRCNPYRDN 266 (323)
Q Consensus 188 ~~~~~~~~GliLvD~K~EFG-~~~~g~iiL~DEv~TPDssR~W~~~~ye~~~~~g~~~~s~DKq~~R~wl~~~~~~~~~~ 266 (323)
+-+++-++|+++=|.|-|== ++.+|.+-|+| +|. +.++-. +.-...... ..+..+-+|.+.. .
T Consensus 130 aL~yLH~~~IiHRDlKpeNILl~~~g~iKL~D-FGl--a~~~~~-~~~~~~~~~-GT~~YmAPEvl~~----~------- 193 (292)
T cd06658 130 ALSYLHNQGVIHRDIKSDSILLTSDGRIKLSD-FGF--CAQVSK-EVPKRKSLV-GTPYWMAPEVISR----L------- 193 (292)
T ss_pred HHHHHHHCCEEECCCCHHHEEECCCCCEEEEE-CCC--CEECCC-CCCCCCEEE-CCCCCCCHHHHCC----C-------
T ss_conf 99999978935363771536786899899972-627--556577-777641140-5748779899809----9-------
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHCCCCC
Q ss_conf 99989899999999999999986088664
Q gi|254780493|r 267 IPDIPENIILRTSQTYIAAYEKITGLKFI 295 (323)
Q Consensus 267 ~P~LP~~vv~~~~~~Y~~~~e~lTG~~f~ 295 (323)
|-+-..++...=+-+||.+||..=+
T Consensus 194 ----~y~~~~DIWSlGvilyeml~G~~Pf 218 (292)
T cd06658 194 ----PYGTEVDIWSLGIMVIEMIDGEPPY 218 (292)
T ss_pred ----CCCCHHHHHHHHHHHHHHHHCCCCC
T ss_conf ----9994899999999999999688999
No 34
>cd05615 STKc_cPKC_alpha STKc_cPKC_alpha: Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with ce
Probab=31.73 E-value=37 Score=14.56 Aligned_cols=33 Identities=27% Similarity=0.358 Sum_probs=25.1
Q ss_pred HHHHHHHCCCEEEEEEEEEE-ECCCCCEEEECCCC
Q ss_conf 99998867978874232445-50886257620004
Q gi|254780493|r 188 GCKLALENGLILVDSKYEFG-IDKKQNIILADEIH 221 (323)
Q Consensus 188 ~~~~~~~~GliLvD~K~EFG-~~~~g~iiL~DEv~ 221 (323)
+-+++-++||++=|.|-|== ++.+|.+-|+| +|
T Consensus 113 aL~yLH~~~IiHRDLKPeNILld~~g~iKL~D-FG 146 (323)
T cd05615 113 GLFFLHRRGIIYRDLKLDNVMLDSEGHIKIAD-FG 146 (323)
T ss_pred HHHHHHHCCCEECCCCCCCEEECCCCCEEEEE-HH
T ss_conf 99999988946466774311387899889854-46
No 35
>cd07832 STKc_CCRK The catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase subfamily. Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the deve
Probab=31.09 E-value=38 Score=14.49 Aligned_cols=114 Identities=13% Similarity=0.032 Sum_probs=53.5
Q ss_pred HHHHHHHHHHHHHHHHHHCCCEEEEEEEEEE-ECCCCCEEEECCCCCCCCCHHHCCCHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 9999999999999998867978874232445-508862576200048100000000000123312544443237888765
Q gi|254780493|r 177 ISSYALSLFERGCKLALENGLILVDSKYEFG-IDKKQNIILADEIHTPDSSRYWEVETYEKSFREGITPIGLDKDFIRNW 255 (323)
Q Consensus 177 i~~~sl~i~~~~~~~~~~~GliLvD~K~EFG-~~~~g~iiL~DEv~TPDssR~W~~~~ye~~~~~g~~~~s~DKq~~R~w 255 (323)
++.....+...+ .++-+.||++-|.|-|== ++.+|.+-|+| +|. ||.+..+........=.++...-+|.+..-
T Consensus 101 i~~~~~qil~aL-~yLH~~~IiHrDiKPeNIll~~~~~vKL~D-FG~---a~~~~~~~~~~~~~~vGT~~Y~APEvl~~~ 175 (286)
T cd07832 101 VKSYMRMLLKGL-AHMHALGIMHRDLKPANLLISADGVLKIAD-FGL---ARLLSEEEPRLYSHQVATRWYRAPELLYGA 175 (286)
T ss_pred HHHHHHHHHHHH-HHHHHCCEEECCCCHHHEEECCCCCEEEEC-CCC---CEECCCCCCCEECCCEECCCCCCHHHHCCC
T ss_conf 999999999999-999989957775876877986999889801-664---513578887420053106765686997089
Q ss_pred HHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Q ss_conf 531122367999998989999999999999998608866478867899999999
Q gi|254780493|r 256 ILTRCNPYRDNIPDIPENIILRTSQTYIAAYEKITGLKFIADNSELPPLERIRN 309 (323)
Q Consensus 256 l~~~~~~~~~~~P~LP~~vv~~~~~~Y~~~~e~lTG~~f~~~~~~~~~~erI~~ 309 (323)
|.- +-..++...=+-+||.+||.+++......+...+|.+
T Consensus 176 ------------~~y--~~~~DiWSlG~i~~ell~G~~~f~~~~~~~~l~~i~~ 215 (286)
T cd07832 176 ------------RKY--GPAVDLWAVGCVFAELLNGSPLFPGEGDIEQLAIVFR 215 (286)
T ss_pred ------------CCC--CCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
T ss_conf ------------888--9756788799999999849899899898999999999
No 36
>pfam08491 SE Squalene epoxidase. This domain is found in squalene epoxidase (SE) and related proteins which are found in taxonomically diverse groups of eukaryotes and also in bacteria. SE was first cloned from Saccharomyces cerevisiae where it was named ERG1. It contains a putative FAD binding site and is a key enzyme in the sterol biosynthetic pathway. Putative transmembrane regions are found to the protein's C-terminus.
Probab=30.60 E-value=38 Score=14.44 Aligned_cols=10 Identities=40% Similarity=0.301 Sum_probs=3.8
Q ss_pred HHHHHHHHHC
Q ss_conf 9999998520
Q gi|254780493|r 311 LRKYTHRHLS 320 (323)
Q Consensus 311 l~~~~~~~~~ 320 (323)
||+-.+.||+
T Consensus 215 Lr~gcF~Yf~ 224 (276)
T pfam08491 215 LRKGCFDYFS 224 (276)
T ss_pred HHHHHHHHHH
T ss_conf 9999999997
No 37
>TIGR00389 glyS_dimeric glycyl-tRNA synthetase; InterPro: IPR002315 The aminoacyl-tRNA synthetases (6.1.1. from EC) catalyse the attachment of an amino acid to its cognate transfer RNA molecule in a highly specific two-step reaction. These proteins differ widely in size and oligomeric state, and have limited sequence homology . The 20 aminoacyl-tRNA synthetases are divided into two classes, I and II. Class I aminoacyl-tRNA synthetases contain a characteristic Rossman fold catalytic domain and are mostly monomeric . Class II aminoacyl-tRNA synthetases share an anti-parallel beta-sheet fold flanked by alpha-helices , and are mostly dimeric or multimeric, containing at least three conserved regions , , . However, tRNA binding involves an alpha-helical structure that is conserved between class I and class II synthetases. In reactions catalysed by the class I aminoacyl-tRNA synthetases, the aminoacyl group is coupled to the 2'-hydroxyl of the tRNA, while, in class II reactions, the 3'-hydroxyl site is preferred. The synthetases specific for arginine, cysteine, glutamic acid, glutamine, isoleucine, leucine, methionine, tyrosine, tryptophan and valine belong to class I synthetases; these synthetases are further divided into three subclasses, a, b and c, according to sequence homology. The synthetases specific for alanine, asparagine, aspartic acid, glycine, histidine, lysine, phenylalanine, proline, serine, and threonine belong to class-II synthetases . In eubacteria, glycyl-tRNA synthetase (6.1.1.14 from EC) is an alpha2/beta2 tetramer composed of 2 different subunits , , . In some eubacteria, in archaea and eukaryota, glycyl-tRNA synthetase is an alpha2 dimer, this family. It belongs to class IIc and is one of the most complex synthetases. What is most interesting is the lack of similarity between the two types: divergence at the sequence level is so great that it is impossible to infer descent from common genes. The alpha (see IPR002310 from INTERPRO) and beta subunits (see IPR002311 from INTERPRO) also lack significant sequence similarity. However, they are translated from a single mRNA , and a single chain glycyl-tRNA synthetase from Chlamydia trachomatis has been found to have significant similarity with both domains, suggesting divergence from a single polypeptide chain . The sequence and crystal structure of the homodimeric glycyl-tRNA synthetase from Thermus thermophilus, shows that each monomer consists of an active site strongly resembling that of the aspartyl and seryl enzymes, a C-terminal anticodon recognition domain of 100 residues and a third domain unusually inserted between motifs 1 and 2 almost certainly interacting with the acceptor arm of tRNA(Gly). The C-terminal domain has a novel five-stranded parallel-antiparallel beta-sheet structure with three surrounding helices. The active site residues most probably responsible for substrate recognition, in particular in the Gly binding pocket, can be identified by inference from aspartyl-tRNA synthetase due to the conserved nature of the class II active site , .; GO: 0000166 nucleotide binding, 0004820 glycine-tRNA ligase activity, 0005524 ATP binding, 0006412 translation, 0006426 glycyl-tRNA aminoacylation, 0005737 cytoplasm.
Probab=29.37 E-value=29 Score=15.24 Aligned_cols=18 Identities=22% Similarity=0.333 Sum_probs=10.0
Q ss_pred CHHHHHHHHHHHHHHHHH
Q ss_conf 788999999999999854
Q gi|254780493|r 51 YKGEVLNQITQYWFHHTS 68 (323)
Q Consensus 51 ~KG~~l~~iS~~~F~~l~ 68 (323)
.||.+-|++=+|+.-+..
T Consensus 292 e~G~i~ne~L~YFia~~~ 309 (606)
T TIGR00389 292 EKGIIENETLAYFIALVK 309 (606)
T ss_pred HCCCCCCHHHHHHHHHHH
T ss_conf 346521006899999999
No 38
>pfam05712 MRG MRG. This family consists of three different eukaryotic proteins (mortality factor 4 (MORF4/MRG15), male-specific lethal 3(MSL-3) and ESA1-associated factor 3(EAF3)). It is thought that the MRG family is involved in transcriptional regulation via histone acetylation. It contains 2 chromo domains and a leucine zipper motif.
Probab=28.73 E-value=41 Score=14.24 Aligned_cols=17 Identities=35% Similarity=0.616 Sum_probs=7.2
Q ss_pred HHHHHHHHHHHHHHHHC
Q ss_conf 99999999999998520
Q gi|254780493|r 304 LERIRNNLRKYTHRHLS 320 (323)
Q Consensus 304 ~erI~~~l~~~~~~~~~ 320 (323)
..+|...|+.|+...++
T Consensus 90 ~~Ev~~Gl~~YFn~~L~ 106 (190)
T pfam05712 90 LEEVVDGLRIYFNKALG 106 (190)
T ss_pred HHHHHHHHHHHHHHHHH
T ss_conf 99999999999998733
No 39
>PRK04028 glutamyl-tRNA(Gln) amidotransferase subunit E; Validated
Probab=28.55 E-value=42 Score=14.22 Aligned_cols=34 Identities=26% Similarity=0.642 Sum_probs=17.3
Q ss_pred CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 544443237888765531122367999998989999999999
Q gi|254780493|r 241 GITPIGLDKDFIRNWILTRCNPYRDNIPDIPENIILRTSQTY 282 (323)
Q Consensus 241 g~~~~s~DKq~~R~wl~~~~~~~~~~~P~LP~~vv~~~~~~Y 282 (323)
.++|..++++++...- ...|+||++......+.|
T Consensus 435 DLPPi~Is~e~Ie~Ik--------~~LPELP~~kr~Rl~~ey 468 (631)
T PRK04028 435 DIPPIRITEELLEKIK--------KNLPELPEEKLERLVKEY 468 (631)
T ss_pred CCCCEECCHHHHHHHH--------HHCCCCHHHHHHHHHHHC
T ss_conf 8774646999999999--------718999999999999970
No 40
>pfam05121 GvpK Gas vesicle protein K. These proteins are involved in the formation of gas vesicles.
Probab=28.36 E-value=42 Score=14.20 Aligned_cols=44 Identities=23% Similarity=0.209 Sum_probs=39.8
Q ss_pred HHHCCCHHHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEEEEE
Q ss_conf 53049989998999999999999999988679788742324455
Q gi|254780493|r 165 HRGILTRNQWETISSYALSLFERGCKLALENGLILVDSKYEFGI 208 (323)
Q Consensus 165 ~~~~~~~~~~~~i~~~sl~i~~~~~~~~~~~GliLvD~K~EFG~ 208 (323)
+.|.++.++.+.+-..-+++-..+.+.+...|+.-.|..+.+|-
T Consensus 39 e~G~Ls~eqiErlG~tLm~le~~~~~L~~~fgl~~~dLnldLgp 82 (89)
T pfam05121 39 ESGSLSDEQIERLGESLQKLEEQLEQLCEQFGIDPEDLNLDLGP 82 (89)
T ss_pred HCCCCCHHHHHHHHHHHHHHHHHHHHHHHHCCCCHHHHCCCCCC
T ss_conf 25899999999999999999999999999829998997314322
No 41
>cd07847 STKc_CDKL1_4 The catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 subfamily. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformatio
Probab=27.38 E-value=44 Score=14.09 Aligned_cols=103 Identities=19% Similarity=0.068 Sum_probs=51.5
Q ss_pred HHHHHCCCEEEEEEEEEE-ECCCCCEEEECCCCCCCCCHHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf 998867978874232445-5088625762000481000000000001233125444432378887655311223679999
Q gi|254780493|r 190 KLALENGLILVDSKYEFG-IDKKQNIILADEIHTPDSSRYWEVETYEKSFREGITPIGLDKDFIRNWILTRCNPYRDNIP 268 (323)
Q Consensus 190 ~~~~~~GliLvD~K~EFG-~~~~g~iiL~DEv~TPDssR~W~~~~ye~~~~~g~~~~s~DKq~~R~wl~~~~~~~~~~~P 268 (323)
.++-++|+++=|.|-|== ++.+|.+-|+| +| .+|+............| .+...-+|.+.. .
T Consensus 114 ~ylH~~~iiHRDlKpeNILl~~~~~iKl~D-FG---~a~~~~~~~~~~~~~~g-T~~Y~APE~~~~---------~---- 175 (286)
T cd07847 114 NFCHKHNCIHRDVKPENILITKQGQIKLCD-FG---FARILTGPGDEYTDYVA-TRWYRAPELLVG---------D---- 175 (286)
T ss_pred HHHHHCCCCCCCCCHHHEEECCCCCEEEEE-CC---CCEECCCCCCCCCCCCC-CCCCCCHHHHCC---------C----
T ss_conf 999988874264551110387899499964-12---53013588876456677-757339999729---------9----
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 9898999999999999999860886647886789999999999
Q gi|254780493|r 269 DIPENIILRTSQTYIAAYEKITGLKFIADNSELPPLERIRNNL 311 (323)
Q Consensus 269 ~LP~~vv~~~~~~Y~~~~e~lTG~~f~~~~~~~~~~erI~~~l 311 (323)
.+-....++...=+-+||.+||+.+++.....+....|.+.+
T Consensus 176 -~~y~~~~DiWSlG~ilyell~G~~~f~~~~~~~~l~~i~~~~ 217 (286)
T cd07847 176 -TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTL 217 (286)
T ss_pred -CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHH
T ss_conf -999977989999999999986899989998589999999974
No 42
>TIGR01811 sdhA_Bsu succinate dehydrogenase or fumarate reductase, flavoprotein subunit; InterPro: IPR011280 This entry represents the succinate dehydrogenase flavoprotein subunit as found in the low-GC Gram-positive bacteria and a few other lineages. This enzyme may act in a complete or partial TCA cycle, or act in the opposite direction as fumarate reductase. In some but not all species, succinate dehydrogenase and fumarate reductase may be encoded as separate isozymes..
Probab=27.26 E-value=42 Score=14.17 Aligned_cols=97 Identities=19% Similarity=0.210 Sum_probs=56.6
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEEE----EE----CCCCCEEEECCCCCCCCCHHHCCCHHHHHHH
Q ss_conf 499899989999999999999999886797887423244----55----0886257620004810000000000012331
Q gi|254780493|r 168 ILTRNQWETISSYALSLFERGCKLALENGLILVDSKYEF----GI----DKKQNIILADEIHTPDSSRYWEVETYEKSFR 239 (323)
Q Consensus 168 ~~~~~~~~~i~~~sl~i~~~~~~~~~~~GliLvD~K~EF----G~----~~~g~iiL~DEv~TPDssR~W~~~~ye~~~~ 239 (323)
.-|....=.+...|+.=+....-.+-++|.+.+-..|== |+ +-..++.|+-|-+=.|--|+|--..-.. .
T Consensus 195 tGGyg~vF~~sTna~~sna~A~~~~Y~~Ga~fAnp~FiQiHPT~iP~~~~~QsKl~LMSESlRndGGRiW~pK~~~D--~ 272 (620)
T TIGR01811 195 TGGYGNVFYLSTNAMNSNASAAWRAYEQGAYFANPEFIQIHPTAIPVDGEFQSKLTLMSESLRNDGGRIWVPKEKND--D 272 (620)
T ss_pred CCCCHHHHHHHHCCCCCHHHHHHHHHHCCCEEECCCEEEECCCCCCCCCCCCHHHHHHHHHHCCCCCEEECCCCCCC--C
T ss_conf 28860222212103442157999998679146367135546722388886222577774653269864724688874--3
Q ss_pred CCCCCCCCCHHHH----HHHHHHCCCCCCCC
Q ss_conf 2544443237888----76553112236799
Q gi|254780493|r 240 EGITPIGLDKDFI----RNWILTRCNPYRDN 266 (323)
Q Consensus 240 ~g~~~~s~DKq~~----R~wl~~~~~~~~~~ 266 (323)
....+..+.++-+ |+|..++-++.-.+
T Consensus 273 ~~~~~~~lrp~~I~e~~rdYfLEr~YP~fGN 303 (620)
T TIGR01811 273 RDANQKKLRPEKIPEDKRDYFLERRYPAFGN 303 (620)
T ss_pred CCHHHHCCCCCCCCCCCCCCHHHCCCCCCCC
T ss_conf 1125422564458888885102200777778
No 43
>TIGR03643 conserved hypothetical protein TIGR03643. This model describes an uncharacterized bacterial protein family. Members average about 90 amino acids in length with several well-conserved uncommon amino acids (Trp, Met). The majority of species are marine bacteria. Few species have more than one copy, but Vibrio cholerae El Tor N16961 has three identical copies.
Probab=27.16 E-value=3 Score=21.50 Aligned_cols=43 Identities=23% Similarity=0.405 Sum_probs=31.6
Q ss_pred HHHHHCCCEEEEEEEEEEECCCCCEEEECCCCCCCCCHHHCCC
Q ss_conf 9988679788742324455088625762000481000000000
Q gi|254780493|r 190 KLALENGLILVDSKYEFGIDKKQNIILADEIHTPDSSRYWEVE 232 (323)
Q Consensus 190 ~~~~~~GliLvD~K~EFG~~~~g~iiL~DEv~TPDssR~W~~~ 232 (323)
++|.+--.-.-+.+.+||+.++.-+.|+-.-+.|.|.+.|.+-
T Consensus 7 emAweDrt~Fe~I~~~~gl~E~evi~lMr~~Lk~~Sf~~WRkR 49 (72)
T TIGR03643 7 EMAWEDRTPFEAIEQQFGLSEKEVIKLMRQNLKPSSFKLWRKR 49 (72)
T ss_pred HHHHCCCCCHHHHHHHHCCCHHHHHHHHHHHCCHHHHHHHHHH
T ss_conf 9998379989999999894999999999963384589999999
No 44
>KOG1000 consensus
Probab=26.06 E-value=17 Score=16.63 Aligned_cols=18 Identities=33% Similarity=0.606 Sum_probs=12.6
Q ss_pred EEEEECCCCCEEEECCCC
Q ss_conf 244550886257620004
Q gi|254780493|r 204 YEFGIDKKQNIILADEIH 221 (323)
Q Consensus 204 ~EFG~~~~g~iiL~DEv~ 221 (323)
.+||+..+|.++|+||+|
T Consensus 207 v~faL~RgGR~llADeMG 224 (689)
T KOG1000 207 VIFALERGGRILLADEMG 224 (689)
T ss_pred HHHHHHCCCEEEEECCCC
T ss_conf 788985387399841245
No 45
>TIGR00601 rad23 UV excision repair protein Rad23; InterPro: IPR004806 All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. Rad23 contains a ubiquitin-like domain that interacts with catalytically active proteasomes and two ubiquitin (Ub)-associated (UBA) sequences that bind Ub. Rad23 interacts with ubiquitinated cellular proteins through the synergistic action of its UBA domains. In humans, Rad23 complexes with the XPC protein.; GO: 0006289 nucleotide-excision repair, 0005634 nucleus.
Probab=24.39 E-value=26 Score=15.51 Aligned_cols=26 Identities=12% Similarity=0.198 Sum_probs=14.5
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHCCC
Q ss_conf 99898999999999999999860886
Q gi|254780493|r 268 PDIPENIILRTSQTYIAAYEKITGLK 293 (323)
Q Consensus 268 P~LP~~vv~~~~~~Y~~~~e~lTG~~ 293 (323)
|.|=+-++.++.++|=.+.+.|+-..
T Consensus 323 P~~L~~lL~~iG~~nPQL~~~I~~h~ 348 (453)
T TIGR00601 323 PQLLPPLLQQIGQENPQLLQQISQHP 348 (453)
T ss_pred HHHHHHHHHHHCCCCHHHHHHHHHCC
T ss_conf 67899999973453737999965260
No 46
>PRK09279 pyruvate phosphate dikinase; Provisional
Probab=23.77 E-value=51 Score=13.67 Aligned_cols=27 Identities=11% Similarity=0.091 Sum_probs=11.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHHHHHCCCE
Q ss_conf 998999899999999999999998867978
Q gi|254780493|r 169 LTRNQWETISSYALSLFERGCKLALENGLI 198 (323)
Q Consensus 169 ~~~~~~~~i~~~sl~i~~~~~~~~~~~Gli 198 (323)
-+.+|++.+++...++ +.+...+.|+.
T Consensus 710 ~t~~El~~~~~~i~~~---~~~~~~~~g~~ 736 (875)
T PRK09279 710 GTVKELKLVKAIIDAV---AEEVFAEKGVK 736 (875)
T ss_pred CCHHHHHHHHHHHHHH---HHHHHHHCCCC
T ss_conf 9899999999999999---99999851998
No 47
>pfam04947 Pox_VLTF3 Poxvirus Late Transcription Factor VLTF3 like. Members of this family are approximately 26 KDa, and are involved in trans-activator of late transcription.
Probab=23.75 E-value=51 Score=13.66 Aligned_cols=14 Identities=0% Similarity=0.048 Sum_probs=6.1
Q ss_pred CCHHHHHHHHHHCC
Q ss_conf 23788876553112
Q gi|254780493|r 247 LDKDFIRNWILTRC 260 (323)
Q Consensus 247 ~DKq~~R~wl~~~~ 260 (323)
++++.+|..|...+
T Consensus 54 it~~~vr~iLKkl~ 67 (171)
T pfam04947 54 VTTTKVLDFLKKLG 67 (171)
T ss_pred CCHHHHHHHHHHCC
T ss_conf 99999999999918
No 48
>cd05613 STKc_MSK1_N STKc_MSK1_N: Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the
Probab=23.70 E-value=51 Score=13.66 Aligned_cols=108 Identities=17% Similarity=0.147 Sum_probs=50.8
Q ss_pred HCCCHHHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEEEE-ECCCCCEEEECCCCCCCCCHHHCCCHHHHHHHCCCCCC
Q ss_conf 04998999899999999999999998867978874232445-50886257620004810000000000012331254444
Q gi|254780493|r 167 GILTRNQWETISSYALSLFERGCKLALENGLILVDSKYEFG-IDKKQNIILADEIHTPDSSRYWEVETYEKSFREGITPI 245 (323)
Q Consensus 167 ~~~~~~~~~~i~~~sl~i~~~~~~~~~~~GliLvD~K~EFG-~~~~g~iiL~DEv~TPDssR~W~~~~ye~~~~~g~~~~ 245 (323)
+-+++.++..+-. .+.. +-.++-++|+++=|.|-|== ++.+|.+.|+| +|. ||....+.-+.....-..+.
T Consensus 100 ~~l~e~~~~~~~~---qil~-al~ylH~~~IiHRDiKpeNILl~~~g~ikl~D-FGl---s~~~~~~~~~~~~~~~GT~~ 171 (290)
T cd05613 100 ERFKEQEVQIYSG---EIVL-ALEHLHKLGIIYRDIKLENILLDSNGHVVLTD-FGL---SKEFHEDEVERAYSFCGTIE 171 (290)
T ss_pred CCCCHHHHHHHHH---HHHH-HHHHHHHCCCEECCCCHHHCCCCCCCCEEECC-CCC---CEEECCCCCCCCCCCCCCCC
T ss_conf 9999999999999---9999-99999988945323663654466899889832-760---11212688754445447802
Q ss_pred CCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCC
Q ss_conf 32378887655311223679999989899999999999999986088664
Q gi|254780493|r 246 GLDKDFIRNWILTRCNPYRDNIPDIPENIILRTSQTYIAAYEKITGLKFI 295 (323)
Q Consensus 246 s~DKq~~R~wl~~~~~~~~~~~P~LP~~vv~~~~~~Y~~~~e~lTG~~f~ 295 (323)
.+.+|.++..- .++ +-..++-..=+-+||.+||..=+
T Consensus 172 Y~APEvl~~~~--~~y-----------~~~~DiWSlGvilyeml~G~~PF 208 (290)
T cd05613 172 YMAPDIVRGGD--GGH-----------DKAVDWWSMGVLMYELLTGASPF 208 (290)
T ss_pred CCCHHHHCCCC--CCC-----------CHHHHHHHHHHHHHHHHHCCCCC
T ss_conf 17899980788--788-----------86776676689999998498998
No 49
>cd07850 STKc_JNK The catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different
Probab=23.43 E-value=52 Score=13.62 Aligned_cols=106 Identities=13% Similarity=0.010 Sum_probs=53.1
Q ss_pred HHHHHHHHHHHHHCCCEEEEEEEEEE-ECCCCCEEEECCCCCCCCCHHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHCC
Q ss_conf 99999999998867978874232445-50886257620004810000000000012331254444323788876553112
Q gi|254780493|r 182 LSLFERGCKLALENGLILVDSKYEFG-IDKKQNIILADEIHTPDSSRYWEVETYEKSFREGITPIGLDKDFIRNWILTRC 260 (323)
Q Consensus 182 l~i~~~~~~~~~~~GliLvD~K~EFG-~~~~g~iiL~DEv~TPDssR~W~~~~ye~~~~~g~~~~s~DKq~~R~wl~~~~ 260 (323)
..+.. +-.++-++|+++-|.|-|== ++.++.+-|+| +|. +|.......... ..| ++...-+|.+.. ..
T Consensus 125 ~Qil~-aL~ylH~~gIiHRDLKPeNILl~~~~~vKL~D-FGl---A~~~~~~~~~~~-~vg-T~~Y~APEvl~~----~~ 193 (353)
T cd07850 125 YQMLC-GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD-FGL---ARTAGTSFMMTP-YVV-TRYYRAPEVILG----MG 193 (353)
T ss_pred HHHHH-HHHHHHHCCCEECCCCHHHEEECCCCCEEECC-CCH---HEECCCCCCCCC-CCC-CCCCCCHHHHCC----CC
T ss_conf 99999-99999878935566875777998999786223-122---000368864468-415-756518999859----99
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Q ss_conf 2367999998989999999999999998608866478867899999999
Q gi|254780493|r 261 NPYRDNIPDIPENIILRTSQTYIAAYEKITGLKFIADNSELPPLERIRN 309 (323)
Q Consensus 261 ~~~~~~~P~LP~~vv~~~~~~Y~~~~e~lTG~~f~~~~~~~~~~erI~~ 309 (323)
++ -..++...=+-+||.+||+..++-....+...+|.+
T Consensus 194 Y~-----------~~vDiWSlGcil~Ell~g~~~F~g~~~~~~l~~I~~ 231 (353)
T cd07850 194 YK-----------ENVDIWSVGCIMGEMIRGSVLFPGTDHIDQWNKIIE 231 (353)
T ss_pred CC-----------CHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
T ss_conf 99-----------655448879999999509999898987999999999
No 50
>pfam10985 DUF2805 Protein of unknown function (DUF2805). This is a bacterial family of proteins with unknown function.
Probab=22.54 E-value=3.9 Score=20.76 Aligned_cols=42 Identities=24% Similarity=0.395 Sum_probs=30.1
Q ss_pred HHHHCCCEEEEEEEEEEECCCCCEEEECCCCCCCCCHHHCCC
Q ss_conf 988679788742324455088625762000481000000000
Q gi|254780493|r 191 LALENGLILVDSKYEFGIDKKQNIILADEIHTPDSSRYWEVE 232 (323)
Q Consensus 191 ~~~~~GliLvD~K~EFG~~~~g~iiL~DEv~TPDssR~W~~~ 232 (323)
+|.+--.-.-+.+.+||+.++..+-|+-.-+.|.|.+.|.+-
T Consensus 7 MAweDrt~FeaI~~~~gl~E~eVi~lMR~~Lk~~Sf~~WRkR 48 (73)
T pfam10985 7 MAWEDRTPFEAIERQFGLSEKEVIKLMRRELKPSSFKLWRKR 48 (73)
T ss_pred HHHCCCCCHHHHHHHHCCCHHHHHHHHHHHCCHHHHHHHHHH
T ss_conf 998269989999999895999999999965374589999999
No 51
>cd05601 STKc_CRIK STKc_CRIK: Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome
Probab=22.52 E-value=54 Score=13.51 Aligned_cols=61 Identities=20% Similarity=0.167 Sum_probs=33.8
Q ss_pred HHHHHHCCCEEEEEEEEEE-ECCCCCEEEECCCCCCCCCHHHCCCHH-HHHHHCCCCCCCCCHHHHHH
Q ss_conf 9998867978874232445-508862576200048100000000000-12331254444323788876
Q gi|254780493|r 189 CKLALENGLILVDSKYEFG-IDKKQNIILADEIHTPDSSRYWEVETY-EKSFREGITPIGLDKDFIRN 254 (323)
Q Consensus 189 ~~~~~~~GliLvD~K~EFG-~~~~g~iiL~DEv~TPDssR~W~~~~y-e~~~~~g~~~~s~DKq~~R~ 254 (323)
-+++-++|+++=|.|-|=- ++.+|.+-|+| +|. ++....+.. ...... ..+..+-+|.++.
T Consensus 115 l~yLH~~gIiHRDiKPeNILld~~g~iKL~D-FGl---a~~~~~~~~~~~~~~~-GTp~YmAPEvl~~ 177 (330)
T cd05601 115 IHSLHQMGYVHRDIKPENILIDRTGHIKLAD-FGS---AAKLNANKMVNSKLPV-GTPDYIAPEVLTS 177 (330)
T ss_pred HHHHHHCCEEECCCCCCCEEECCCCCEEEEE-CCC---EEEECCCCCEECCCCC-CCHHHCCHHHHHC
T ss_conf 9999748688454650003465899889802-655---4771588845405766-8810189999825
No 52
>PTZ00034 40S ribosomal protein S10; Provisional
Probab=22.49 E-value=36 Score=14.65 Aligned_cols=22 Identities=18% Similarity=0.457 Sum_probs=13.3
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 7888765531122367999998989999999999
Q gi|254780493|r 249 KDFIRNWILTRCNPYRDNIPDIPENIILRTSQTY 282 (323)
Q Consensus 249 Kq~~R~wl~~~~~~~~~~~P~LP~~vv~~~~~~Y 282 (323)
=|++|+||+ ||++||-.|-++=
T Consensus 84 IeYLR~yLh------------LP~eiVPaTlkk~ 105 (137)
T PTZ00034 84 IEYLREFLH------------LPPSIFPATLSKK 105 (137)
T ss_pred HHHHHHHHC------------CCCHHCCHHHHCC
T ss_conf 999998746------------9920177655213
No 53
>cd07864 STKc_CDK12 The catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 subfamily. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. C
Probab=22.22 E-value=55 Score=13.47 Aligned_cols=100 Identities=17% Similarity=0.077 Sum_probs=47.5
Q ss_pred HHHHHHHHHHHHHHCCCEEEEEEEEEE-ECCCCCEEEECCCCCCCCCHHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHC
Q ss_conf 999999999998867978874232445-5088625762000481000000000001233125444432378887655311
Q gi|254780493|r 181 ALSLFERGCKLALENGLILVDSKYEFG-IDKKQNIILADEIHTPDSSRYWEVETYEKSFREGITPIGLDKDFIRNWILTR 259 (323)
Q Consensus 181 sl~i~~~~~~~~~~~GliLvD~K~EFG-~~~~g~iiL~DEv~TPDssR~W~~~~ye~~~~~g~~~~s~DKq~~R~wl~~~ 259 (323)
...+-. +-.++-++|+++=|.|-|== ++.+|.+-|+| +| .||+...++..........+...-+|.+..-
T Consensus 122 ~~Qil~-gL~yLH~~giiHRDlKPeNILi~~~~~vKl~D-FG---~a~~~~~~~~~~~~~~~~T~~Y~APEvl~~~---- 192 (302)
T cd07864 122 MKQLLE-GLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD-FG---LARLYNAEESRPYTNKVITLWYRPPELLLGE---- 192 (302)
T ss_pred HHHHHH-HHHHHHHCCCEECCCCHHHEEECCCCCEEEEE-CC---CCEECCCCCCCCCCCCCCCCCCCCHHHHCCC----
T ss_conf 999999-99999869946045876986998999889975-68---7510467777413450045176580231598----
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 2236799999898999999999999999860886647886
Q gi|254780493|r 260 CNPYRDNIPDIPENIILRTSQTYIAAYEKITGLKFIADNS 299 (323)
Q Consensus 260 ~~~~~~~~P~LP~~vv~~~~~~Y~~~~e~lTG~~f~~~~~ 299 (323)
... +-..++-..=+-+||.+||.+++..+.
T Consensus 193 --~~y--------~~~~DIWSlG~il~em~~g~p~f~~~~ 222 (302)
T cd07864 193 --ERY--------GPAIDVWSCGCILGELFTKKPIFQANQ 222 (302)
T ss_pred --CCC--------CCHHHCCHHHHHHHHHHHCCCCCCCCC
T ss_conf --898--------953334257899999954999989998
No 54
>PHA02130 hypothetical protein
Probab=21.84 E-value=55 Score=13.43 Aligned_cols=28 Identities=21% Similarity=0.420 Sum_probs=19.6
Q ss_pred CCCCCCCCCHHHHHHHHHHCCCCCCCCC
Q ss_conf 2544443237888765531122367999
Q gi|254780493|r 240 EGITPIGLDKDFIRNWILTRCNPYRDNI 267 (323)
Q Consensus 240 ~g~~~~s~DKq~~R~wl~~~~~~~~~~~ 267 (323)
.|.....-+=|.+|+||.+++..|.+.+
T Consensus 7 ~gkektfks~~sl~~wl~~~~dswdddi 34 (81)
T PHA02130 7 TGKEKTFKSWESLREWLDERFDSWDDDI 34 (81)
T ss_pred CCCCCHHHHHHHHHHHHHHCCCCCCCCH
T ss_conf 7640036779999999982026533320
No 55
>TIGR02800 propeller_TolB Tol-Pal system beta propeller repeat protein TolB; InterPro: IPR014167 Members of this protein family are the TolB periplasmic protein of Gram-negative bacteria. TolB is part of the Tol-Pal (peptidoglycan-associated lipoprotein) multiprotein complex, comprising five envelope proteins, TolQ, TolR, TolA, TolB and Pal, which form two complexes. The TolQ, TolR and TolA inner-membrane proteins interact via their transmembrane domains. The {beta}-propeller domain of the periplasmic protein TolB is responsible for its interaction with Pal. TolB also interacts with the outer-membrane peptidoglycan-associated proteins Lpp and OmpA. TolA undergoes a conformational change in response to changes in the proton-motive force, and interacts with Pal in an energy-dependent manner. The C-terminal periplasmic domain of TolA also interacts with the N-terminal domain of TolB. The Tol-PAL system is required for bacterial outer membrane integrity. Escherichia coli TolB is involved in the tonB-independent uptake of group A colicins (colicins A, E1, E2, E3 and K), and is necessary for the colicins to reach their respective targets after initial binding to the bacteria. It is also involved in uptake of filamentous DNA. Study of its structure suggests that the TolB protein might be involved in the recycling of peptidoglycan or in its covalent linking with lipoproteins. The Tol-Pal system is also implicated in pathogenesis of E. coli, Haemophilus ducreyi, Salmonella enterica and Vibrio cholerae, but the mechanism(s) is unclear..
Probab=21.70 E-value=45 Score=14.03 Aligned_cols=24 Identities=21% Similarity=0.102 Sum_probs=11.6
Q ss_pred HHHHHHHHHHHHHHHH-HHHHHHCC
Q ss_conf 9989999999999999-99988679
Q gi|254780493|r 173 QWETISSYALSLFERG-CKLALENG 196 (323)
Q Consensus 173 ~~~~i~~~sl~i~~~~-~~~~~~~G 196 (323)
..++++..|+++...+ +++.-++|
T Consensus 139 ~~~~~R~~AH~iaD~iye~LTG~~G 163 (439)
T TIGR02800 139 TASQLRRVAHRIADAIYEKLTGERG 163 (439)
T ss_pred CHHHHHHHHHHHHHHHHHHHCCCCC
T ss_conf 4789887855888989998568998
No 56
>cd07836 STKc_Pho85 The catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 subfamily. Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the
Probab=21.32 E-value=57 Score=13.36 Aligned_cols=43 Identities=23% Similarity=0.307 Sum_probs=28.1
Q ss_pred HHHHHHHHHHHHHHHHHHCCCEEEEEEEEEEE-CCCCCEEEECCCC
Q ss_conf 99999999999999988679788742324455-0886257620004
Q gi|254780493|r 177 ISSYALSLFERGCKLALENGLILVDSKYEFGI-DKKQNIILADEIH 221 (323)
Q Consensus 177 i~~~sl~i~~~~~~~~~~~GliLvD~K~EFG~-~~~g~iiL~DEv~ 221 (323)
++.....+-..+ .++-++||++=|.|-|==+ +.+|.+-|+| +|
T Consensus 102 i~~~~~Qil~aL-~ylH~~gIiHRDlKP~NILl~~~~~vKL~D-FG 145 (284)
T cd07836 102 VKSFTYQLLKGI-AFCHENRVLHRDLKPQNLLINKRGELKLAD-FG 145 (284)
T ss_pred HHHHHHHHHHHH-HHHHHCCEEEEECCCCEEEECCCCCEEEEE-CC
T ss_conf 999999999999-999978915421561106998999889976-37
Done!